<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Sherbit News - Medium]]></title>
        <description><![CDATA[To help people understand and use their personal data - Medium]]></description>
        <link>https://medium.com/sherbit-news?source=rss----988c3400cf87---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>Sherbit News - Medium</title>
            <link>https://medium.com/sherbit-news?source=rss----988c3400cf87---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 13:14:37 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/sherbit-news" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[HealthTech Company Medopad to expand into the US with Acquisition of Health AI startup, Sherbit]]></title>
            <link>https://medium.com/sherbit-news/healthtech-company-medopad-to-expand-into-the-us-with-acquisition-of-health-ai-startup-sherbit-7ee795eb82e4?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/7ee795eb82e4</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[acquisition]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[ai]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Tue, 11 Sep 2018 19:14:03 GMT</pubDate>
            <atom:updated>2018-09-11T19:13:54.418Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/577/1*F-1lFO6RTe8feEL1sAdLig.jpeg" /></figure><p>Medopad, the UK HealthTech company aiming to extend the lives of 1 billion people worldwide, has today announced its first acquisition as it accelerates its expansion into the US.</p><p>The company, which was named as a <a href="https://www.linkedin.com/pulse/kpmg-medopad-1b-healthtech-company-making-dan-vahdat/">$1billion</a> HealthTech business in the making by KPMG, has acquired <a href="https://www.sherbit.io/">Sherbit</a>, a Silicon Valley AI startup that works with the largest US healthcare systems to improve chronic disease patient care. Medopad’s unique technology connects patients with health-care professionals, allowing them to analyze a patient’s data and detect life-threatening medical conditions.</p><p>It works with Royal Free London, Guy’s and St Thomas’, Bart’s, Chelsea &amp; Westminster in the UK and is working on projects in counties including China, Germany, and Singapore. Medopad partners with the world’s largest healthcare systems, pharma companies and technology companies such as Apple and Tencent to solve some of the biggest problems in rare, chronic and complex disease monitoring.</p><p>Medopad CEO and Founder Dan Vahdat said: “At Medopad we want to create a world where people can live longer. We are working with some of the biggest companies in the world to improve the way doctors care for their patients by monitoring them at home and spotting any complications before they arise.” “We are expanding rapidly across the world and acquiring Sherbit is just the first step for us in the US.</p><p>“Sherbit has a strong track record of success working with some of the most prestigious healthcare organizations in the US, including the Mayo Clinic, Tufts Medical Center and Jefferson Health. Through this acquisition, Medopad will provide its technology to support solutions across different disease areas from rare diseases to chronic conditions.”</p><p>Sherbit CEO Alex Senemar said: “Sherbit and Medopad have the same vision to help people be healthier and live longer. We’re excited to leverage Medopad’s technology, clinical, and predictive analytics capabilities to expand what’s possible for our customers.”</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7ee795eb82e4" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/healthtech-company-medopad-to-expand-into-the-us-with-acquisition-of-health-ai-startup-sherbit-7ee795eb82e4">HealthTech Company Medopad to expand into the US with Acquisition of Health AI startup, Sherbit</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[New Study Between Tufts Medical Center and Sherbit Finds that Guided Remote Interventions Lead to…]]></title>
            <link>https://medium.com/sherbit-news/new-study-at-tufts-medical-center-shows-that-remote-interventions-lead-to-better-outcomes-for-a08c6638e748?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/a08c6638e748</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[big-data]]></category>
            <category><![CDATA[diabetes]]></category>
            <category><![CDATA[hypertension]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Thu, 26 Apr 2018 17:42:01 GMT</pubDate>
            <atom:updated>2018-04-26T19:55:43.347Z</atom:updated>
            <content:encoded><![CDATA[<h3>New Study Between Tufts Medical Center and Sherbit Finds that Guided Remote Interventions Lead to Better Outcomes for Hypertensive &amp; Diabetic Patients</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/576/1*j1tI_DQc3dRT-FyZ2SZiQQ.png" /></figure><p>Chronic medical conditions often require a higher level of care yet most patients who live with chronic disease don’t have the time, money or access to see a physician so frequently. There is now evidence that digital therapeutics can play a role in chronic disease management by reducing costs, increasing access to care while improving outcomes on a population scale.</p><p>The 7-week long pilot study was conducted at Tufts Medical Center (Boston, MA) with the Sherbit digital health platform on patients with type 2 diabetes mellitus and hypertension. The study used internet connected blood pressure monitors from iHealth to monitor patients in real time and engage them with text messages based on behavioral economics. Patients received individualized messages with tailored advice and encouragement promoting a healthy lifestyle (exercise and diet) and increased medication compliance.</p><p>At the beginning of the trial, patients completed questionnaires to establish a baseline about their health goals and medication adherence. They were then asked to take blood pressure measurements twice a day for seven weeks. The data was wirelessly collected via healthcare analytics platform, Sherbit and accessible to the research staff for review in real-time.</p><p>All patients reported the blood pressure monitoring to be useful, and nearly all (89%) found it easy to use. At the end of the study, 82% of participants reported high medication adherence compared to 75% at baseline. Among the participants, mean blood pressure improved from 147/84 mmHg (week 0) to 143/81 mmHg (week 4–7) and HbA1c was drastically lowered in all patients.</p><p>About Tufts Medical Center</p><p>Tufts Medical Center is an internationally-respected academic medical center — a teaching hospital where that prides itself not only in the sophistication of the care provided but the compassionate way in which it is delivered. Tufts Medical Center cares for all patients from the tiniest newborns at their full-service pediatric hospital, <a href="http://www.floatinghospital.org/">Floating Hospital for Children</a> to centenarians in at their specialized Geriatrics clinic.</p><p>About Sherbit</p><p>Sherbit helps providers succeed in the digital health era with real-time data and actionable insights about their patients. Care teams can monitor patients through 100+ connected health devices to effectively engage them with coaching, action plans, and preventative alerts. Sherbit’s algorithms look through the patient’s data to find anomalies and alert providers prior to an adverse event. Sherbit was recently recognized by the Harvard Medical School as the most innovative company in primary care as well as one of the most promising healthcare companies by Partners Healthcare. To learn more, please visit: <a href="https://www.sherbit.io/">www.sherbit.io</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a08c6638e748" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/new-study-at-tufts-medical-center-shows-that-remote-interventions-lead-to-better-outcomes-for-a08c6638e748">New Study Between Tufts Medical Center and Sherbit Finds that Guided Remote Interventions Lead to…</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Connecting Fitbit to HealthKit: A Better Apple Health App]]></title>
            <link>https://medium.com/sherbit-news/connecting-fitbit-to-healthkit-a-better-apple-health-app-822cf073dff2?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/822cf073dff2</guid>
            <category><![CDATA[researchkit]]></category>
            <category><![CDATA[fitbit]]></category>
            <category><![CDATA[quantified-self]]></category>
            <category><![CDATA[apple-health-kit]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Mon, 19 Sep 2016 19:34:13 GMT</pubDate>
            <atom:updated>2016-09-19T19:33:55.854Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/0*Y4ToEqrtqR_GY6JR.png" /></figure><h4>Apple Health App’s Unfulfilled Potential</h4><p>In June 2014, Apple <a href="https://www.technologyreview.com/s/527921/why-apple-wants-to-help-you-track-your-health/">first revealed</a> its <strong>Apple Health app</strong> at the Worldwide Developers Conference, promising a centralized platform for managing your health and fitness data — from step counts and heart rates recorded by wearable devices, to blood sugar and cholesterol levels input manually. The announcement of an Apple Health app was met with <a href="http://www.pharmexec.com/first-footfall-what-apple-s-healthkit-announcement-means-healthcare">much fanfare</a>; in particular, commentators were excited about potential breakthroughs in health care research by incorporating the Healthkit platform into <a href="https://9to5mac.com/2015/07/13/researchkit-big-pharma/">pharmaceutical research and development</a>, and clinical programs to help doctors <a href="http://hitconsultant.net/2015/02/05/14-top-hospitals-are-piloting-apples-healthkit-platform/">treat patients with asthma and diabetes</a>.</p><p>Apple’s plans were (and are) certainly ambitious — but, two years later, is HealthKit living up to its potential? Researchers are hard at work on programs that <a href="https://www.sherbit.io/apple-wants-your-dna/">collect DNA</a> from iPhone-owning volunteers; and IBM has developed a <a href="https://www.technologyreview.com/s/536846/apple-and-ibms-plan-to-make-smarter-health-tracking-iphone-apps/">new online service</a> for analyzing Healthkit data and identifying “medically useful” patterns in users’ information. However, the full benefits of HealthKit have yet to be realized due to three critical limitations to the Apple Health app:</p><p>1. <strong>It doesn’t integrate with Fitbit</strong> (and many other major health-tracking devices). Apple’s Health integration only works in one direction; in other words, other applications can share information with the Apple Health app, but Apple won’t send any information back. This has prevented many major players in the wearable industry from joining the Healthkit platform — including Fitbit, the <a href="http://www.wareable.com/wearable-tech/how-many-apple-watches-sold-2016">world’s top-selling fitness tracker</a>. Rather than develop tools for managing the flow of data between applications, Apple has stood by its traditional strategy of a <a href="http://www.forbes.com/sites/timworstall/2012/08/31/the-problem-with-apples-closed-apps-universe/#23425c013153">closed system</a>.</p><p>2. <strong>The data is stuck on your device.</strong> Apple Health is not cloud-based; it can’t be connected with other applications unless they are available on the App Store and installed directly on your phone. Again, Apple has justified this move in terms of <a href="https://www.wired.com/2016/06/apples-differential-privacy-collecting-data/">privacy and security</a> — but the practical consequence is that an enormous number of relevant health indicators are left out of the platform. Unless a device or tool is designed specifically for iPhone, you can’t take advantage of its information. That excludes important software like <a href="https://www.rescuetime.com/">RescueTime</a> (which sits in your desktop browser and tracks how you spend time on the internet) that can provide valuable insights into medical conditions, including <a href="https://www.psychologytoday.com/blog/sleepless-in-america/201109/sleep-and-the-internet-addict">sleep disorders</a> and<a href="http://www.nytimes.com/2012/06/17/opinion/sunday/how-depressed-people-use-the-internet.html?_r=0">depression</a>.</p><p>3. <strong>It doesn’t provide a holistic view.</strong> The Apple Health app only draws data from apps that fall under their narrow criteria for ‘health and fitness.’ But, as the example of RescueTime example illustrates, more diverse data sources are necessary to get a complete picture of health. For example, apps like<a href="https://www.automatic.com/">Automatic</a>, which collects information your driving habits, can help you learn about how <a href="http://time.com/9912/10-things-your-commute-does-to-your-body/">your commute may affect your health</a>. Researchers at the University of Pennsylvania have suggested that the content of your Twitter posts <a href="https://www.sherbit.io/twitter-posts-predict-rates-of-heart-disease/">strongly correlates to your likelihood of heart disease</a>, and another recent study has demonstrated a link between <a href="https://www.technologyreview.com/s/602208/how-an-algorithm-learned-to-identify-depressed-individuals-by-studying-their-instagram/">choice of Instagram filters and incidence of depression</a>. None of these data sources are available in Apple Health.</p><h4>A Better Apple Health App</h4><p>We’re building a cloud-based personal analytics platform that corrects all the areas the Apple Health app comes up short. We’re committed to protecting your privacy, and security is one of our top concerns — we don’t share your information with anybody, we just build the most cutting-edge tools for understanding your data. Download the Sherbit app <a href="https://itunes.apple.com/us/app/sherbit-personal-analytics/id918023785?mt=8">on the App Store</a> to try it for yourself!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/368/0*hpwwWP6QhdB4oMoi.png" /></figure><p>A cloud-based app opens new possibilities for generating insights into your data and staying on top of your health. The Apple Health app only updates its data when a connected app is opened by the user; in other words, it’s not always “current,” and it can only show you information you’ve already seen. Sherbit collects information directly from the app’s server, so you’re always seeing the most accurate and up-to-date data stream. And, it means you can integrate seamlessly with <em>all</em> your apps and devices — including Fitbit.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/309/0*UhWLr0FpvOpFYx2x.png" /></figure><p>ResearchKit is a promising platform, but unless you are <a href="http://fortune.com/2015/03/13/apple-researchkit-apps-available/">directly participating in a study</a>, you won’t see any “results” from your data until major research projects have completed and papers have been published. But with just a few minutes to connect your services to Sherbit, you’ll be able to make instant visual comparisons of graphs from many diverse data streams, and receive periodic e-mails summarizing and breaking down your activity. We’re currently developing real-time insights — algorithms that discover patterns in your data, highlight those patterns to <a href="http://www.cond.org/hullman_adar_shah_camera_ready.pdf">help you “read” your graphs</a>, and push “smart” notifications that alert you when there are anomalies and fluctuations.</p><p>Unlike the Apple Health app, Sherbit is not tied down to a single platform — although the app is currently available for iPhone only, we are working tirelessly on developing a web-based client and an Android app. (<a href="http://sherbit.us9.list-manage.com/subscribe?u=f0fdae444fb5bf7ab6c56e81f&amp;id=943a5f1ba7">Click here</a> to be notified with the Android app is available). If you have an iPhone, <a href="https://itunes.apple.com/us/app/sherbit-personal-analytics/id918023785?mt=8">download the app for free</a> from the App Store. We’re constantly looking for ways to improve our platform, so don’t forget to <a href="/service/mailto:info@sherbit.io">shoot us an e-mail</a> and let us know what you think!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=822cf073dff2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/connecting-fitbit-to-healthkit-a-better-apple-health-app-822cf073dff2">Connecting Fitbit to HealthKit: A Better Apple Health App</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Faster, Not Smarter: Does Caffeine Really Improve Your Productivity?]]></title>
            <link>https://medium.com/sherbit-news/faster-not-smarter-does-caffeine-really-improve-your-productivity-8bd853bc3171?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/8bd853bc3171</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[productivity]]></category>
            <category><![CDATA[sleep]]></category>
            <category><![CDATA[analytics]]></category>
            <category><![CDATA[big-data]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Tue, 02 Aug 2016 20:57:26 GMT</pubDate>
            <atom:updated>2016-08-02T20:57:07.930Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*7sbiL5VdaogaBQxP.gif" /></figure><p>With over <a href="https://www.realcoffee.co.uk/coffee-encyclopedia/trivia/consumption-facts/">four hundred <em>billion</em> cups of coffee consumed</a> each year, caffeine is by far the world’s most widely-consumed psychoactive drug. For many of us, a hot cup of coffee proves to be a powerful and potent stimulant — a necessity to start the day. But caffeine’s effects vary significantly from person to person, and its actual effects on productivity remains unclear. Beyond anecdotal evidence, <a href="http://www.ncbi.nlm.nih.gov/pubmed/20888549">numerous studies</a> show that, in small doses, caffeine provides an increase in energy and alertness, while improving reaction time and cognitive performance. But is coffee really making you more productive?</p><h4>What does the research say?</h4><p>The effects of caffeine on productivity have been a topic of considerable academic interest — researchers at <a href="http://hub.jhu.edu/2014/01/12/caffeine-enhances-memory/">Johns Hopkins University</a> recently found that consuming small amount of caffeine can have a positive effect on long-term memory. In a double-blind trial, participants were given either a 200-milligram caffeine tablet or a placebo, and were asked to study a series of images. The next day, both groups were shown a new set of images, including pictures that were visually similar to the previous — the caffeine group was better able to identify these new images as “similar” rather than citing them as the “same.” In a paper published in <a href="http://www.nature.com/neuro/journal/v17/n2/full/nn.3623.html">Nature Neuroscience</a>, the researchers wrote that this ability to recognize the difference between similar but not identical items — called “pattern separation” — suggests that the caffeine group benefited from greater memory retention.</p><p>However, other research suggests that many of the benefits of caffeine can be <a href="http://www.newyorker.com/tech/elements/how-caffeine-can-cramp-creativity">replicated by placebo</a>.</p><p>In another <a href="http://www.ncbi.nlm.nih.gov/pubmed/21824504">double-blind study</a> at the University of East London, participants were randomly given either caffeinated or decaffeinated coffee — half were told they were regular coffee, and half that they were given decaf, also at random. Interestingly, the participants who were <em>told</em> that they received caffeinated coffee performed better on tests <a href="https://en.wikipedia.org/wiki/Stroop_effect">measuring reaction time</a>, self-control, and <a href="http://cafeesaude.com/wp-content/uploads/2012/01/Humor-L-Dawkins-et-al-Appetite-2011-Article-in-Press-July.pdf">reward motivation</a>. The researchers concluded that the relationship between caffeine consumption, mood, and performance depends on many individual psychological variables — strangely, <em>all</em> participants in the study reported increased feelings of depression after drinking coffee, although this increase was slightly lower in the group that received caffeine.</p><p>Research also shows that caffeine also has a complex effect on <em>creativity</em>. Maria Konnikova observed in<a href="http://www.newyorker.com/tech/elements/how-caffeine-can-cramp-creativity">The New Yorker</a> that “creative insights and imaginative solutions often occur when we stop working on a particular problem and let our mind move on to something unrelated.” As evidence, she pointed to a<a href="http://www.ncbi.nlm.nih.gov/pubmed/22941876">2012 study</a> in which participants performed better in creative thinking exercises (for example, devising novel and inventive uses for an everyday object like a newspaper) after they had allowed their mind to “wander” by switching between “undemanding,” low-intensity tasks. This suggests that caffeine may assist more in very simple, repetitive tasks like checking e-mails or filling out forms, and less in jobs that require high levels of insight and creative thinking.</p><p>And, for the same reasons caffeine increases alertness and wakefulness, it also has a tendency to cause anxiety, jitteriness, and sleeplessness. Scientists at Rice University studied the effects of caffeine on sleep — they observed that a typical cup of coffee decreased the average sleep time of study participants by an average of <em>two hours</em>; it also increased the amount of time it took to fall asleep by thirty percent. Coffee also had significant effects on quality of sleep: the number of sleep awakenings in the experiment subjects <em>doubled</em>. These conclusions has been reproduced in <a href="http://link.springer.com/chapter/10.1007%2F978-1-60327-343-5_33">numerous studies</a>, and suggest a significant risk of impairing your creativity and productivity if you don’t properly manage your caffeine intake.</p><p>Many people don’t know that the human body naturally <a href="http://www.fastcompany.com/3026642/work-smart/your-bodys-natural-caffeination-why-coffee-can-wait">“caffeinates”</a> itself with the hormone cortisol at specific times of day, depending on your <a href="https://www.sciencedaily.com/terms/circadian_rhythm.htm">body’s natural circadian rhythm</a> — typically early in the morning (between 8am and 9am), around lunch time (between 12pm and 1pm), and once again in the late afternoon (from 530pm to 630pm). If you are an avid coffee drinker, you may be impairing your body’s ability to produce cortisol — by drinking coffee when it’s not needed, i.e. when your body is attempting to naturally energize itself according to its hormonal cycles, you may build a faster tolerance to it.</p><h4>Test it for yourself!</h4><p>All the research shows a complex interaction between caffeine and bodily cycles — so instead of relying on the abstract conclusions of large-scale studies, how can you determine the specific effects caffeine has on <em>your</em> body? Caffeine’s effects depends on dosage, body type, weight, age, time of day, and many other factors; so it’s best to monitor all these variables by collecting your own data. First, you need to make sure you’re collecting accurate information: here are some tools we recommend.</p><p><strong><em>Rescuetime</em></strong></p><p><a href="http://www.rescuetime.com/">RescueTime</a> records how much time you spend using computer applications and browsing web sites. It allows you to keep track of how you are spending every minute of the day, and when and how you are wasting time, and it doesn’t require any effort to set up! It simply runs in the background and stays on top of your browsing habits for you.</p><p><strong><em>Jawbone UP Coffee</em></strong></p><p><a href="https://itunes.apple.com/us/app/up-coffee/id828031130?mt=8">Jawbone UP Coffee</a> is a great app for tracking your coffee intake — it’s a simple tool for logging your coffee, tea, and energy drink consumption, to see how it changes overtime.</p><p><strong><em>Sherbit</em></strong></p><p><a href="https://sherbit.io/"><em>Sherbit</em></a> is a personal dashboard that gives you access and control of your personal data in one place. The app syncs with over twenty-five applications including Facebook, Fitbit, Uber and Withings to gather and visualize data. From there, you can identify patterns in your daily habits and correlations across multiple services. For example, if you wanted to find out if you were less active on days you worked more, you could add steps counted by your Fitbit and productivity hours tracked by RescueTime. Download Sherbit from the the App Store by clicking here[<a href="https://itunes.apple.com/us/app/sherbit/id918023785?mt=8">https://itunes.apple.com/us/app/sherbit/id918023785?mt=8</a>]</p><p>Here are some results from our own test:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*Ee03ur4Aaf3_mQd7.png" /></figure><p>By combining the data from Jawbone UP and RescueTime, I found a correlation between caffeine and productivity. You can see this by looking at the trend lines and flipping between the tabs at the top of the chart.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/951/0*o3HDT3_glhY7ULrq.png" /></figure><p>However, I found an even stronger correlation with my sleep and productivity — the more coffee I drank, the less sleep I got. This seem to be true for everyday other than JuIy 22nd and July 29th, but as I looked closer I realized that I had consumed coffee earlier in the morning on those days. This may seem like an obvious conclusion in retrospect, but being able to visualize the data made the effects of coffee on my life much more apparent to me. By reflecting on my data, I realized that there’s is a dual effect on the relationship between coffee and sleep: caffeine affects my quality of sleep and reduces the length of time I’m awake… however, when I don’t get much sleep the previous night, I tend to drink more coffee the next day, perpetuating the cycle. I also noticed that my quality of sleep decreases much more significantly when I drink coffee late in the afternoon — I realized that caffeine tends to work best early in the morning, when it will have a minimal effect on my sleep that night.</p><p>Try <a href="http://www.sherbit.io/">Sherbit</a> out for yourself! Let us know about your results in the comments below — and look forward to our next post, investigating the relationship between <em>driving</em> and productivity. Learn more about our app at our website: <a href="https://sherbit.io/">https://sherbit.io</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8bd853bc3171" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/faster-not-smarter-does-caffeine-really-improve-your-productivity-8bd853bc3171">Faster, Not Smarter: Does Caffeine Really Improve Your Productivity?</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[On HealthKit, Granola, and JSON with Sherbit]]></title>
            <link>https://medium.com/sherbit-news/on-healthkit-granola-and-json-with-sherbit-2cad50c78cb6?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/2cad50c78cb6</guid>
            <category><![CDATA[mobile-app-development]]></category>
            <category><![CDATA[big-data]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[api]]></category>
            <category><![CDATA[healthit]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Thu, 09 Jun 2016 18:01:28 GMT</pubDate>
            <atom:updated>2016-06-09T18:01:08.957Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*RKerWIsD8ZCOrCUO.jpg" /></figure><p>When building our iOS app, Sherbit, we were faced with a daunting task early on: integrating data from disparate sources and standardizing them in such a way that we could easily and dynamically create beautiful user-facing visualizations.</p><p>At first, the solution seems simple. All the services that we integrate maintain a REST API (a URL-based system for delivering data) and as such, our solution was then to build a “Sherbit” API, which would normalize all the third-party data in a graph-able way and send them to the Sherbit iOS client.</p><p>The problem is that Apple’s HealthKit isn’t a normal API. Unlike every other data source we integrate with at Sherbit, HealthKit is an iOS API — the acquisition of data happens directly on the device and away from the Sherbit API.</p><p>This is is a common problem for app developers trying integrate data from HealthKit. Unless you architect your entire app exclusively around HealthKit, you end up with a lot of messy “if health kit x else y” code. HealthKit integration isn’t a trivial process either — unlike many of the other historical-data driven iOS APIs offered by Apple, HealthKit is complex object-driven API comprising of 30+ distinct classes, multiple protocols, and block-driven execution.</p><p>This isn’t necessarily a bad thing — the wealth of data available from HealthKit is vast and detailed. Apple provides you with full unit support, dynamic querying options, and a lot more. This is what makes HealthKit stand out from your average Health/Wearable/IoT REST API. The complexity and uniqueness isn’t the only problem caused by HealthKit. Because the fetching of data is tied to the iPhone itself, you can’t store HealthKit data the same way you can store data provided by REST APIs. Apple does not provide a server facing API for HealthKit, and the iOS client will always be involved in the fetching and storing of data. (This is true for other iOS-centric solutions available from Apple. CloudKit, Apple’s competition to Google’s Firebase and Facebook’s now defunct Parse also does not offer a server-facing API).</p><p>These issues can be at least somewhat remedied with Granola, which is a handy HealthKit-to-JSON serialization library, maintained by the awesome people at Open mHealth (who also maintain a number of free and open source projects standardizing the collection, analysis, storage, and visualization of heath &amp; fitness data from disparate sources). Granola quickly and easily converts data from HealthKit into JSON, which is a much friendlier format for what we need to do here at Sherbit. JSON structures can be easily sent to our API, standardized the same way every other kind of data is, made graph-able, and sent to our iOS Client (or any other client we might release).</p><p>This means a few things:</p><p>1) Less HealthKit Specific UI Code</p><p>Once HealthKit data has been serialized into JSON and sent to our API, we can retrieve it the same way we retrieve any data at Sherbit. This means that code used to retrieve data and turn it into a UI can be re-used for HealthKit.</p><p>2) HealthKit becomes more ubiquitous on your platform</p><p>If you’ve got 1 value for “steps taken” on your iOS client, and a different value on your web client, users will notice. By making HealthKit data accessible via your API instead of directly on the device, you can ensure that the same values appear everywhere and not just on your iOS client.</p><p>3) You get access to the power of HealthKit</p><p>Many device &amp; services do not offer a REST API, and their data is only accessible via HealthKit. Many users have (sometimes inadvertently) poured tons of data into HealthKit — data which you can’t access anywhere else. Apple has the clout to access data that you likely cannot — along with a user facing app used by many people. Even if you don’t like Apple’s Health.app (I certainly don’t), there are certainly benefits to it being built directly on everyone’s iPhone.</p><p>4) Granola doesn’t compromise details to get JSON structures.</p><p>Granola serializes everything, and I mean everything, attached to HealthKit data. Vendor information, device serial numbers — literally every field in HealthKit data structures. They’ve already done the work to look at every field in every HealthKit class definition. Even data you didn’t know you had or wanted is available.</p><p>Granola has become an essential part of HealthKit integration at Sherbit. Without it, we wouldn’t be able to offer as many HealthKit metrics as we do. We can treat HealthKit just as we treat any other piece of data, and quickly add HealthKit metrics to our app as we see fit. If you work with REST APIs and health data, and you’re considering adopting HealthKit, I would take a serious look at Granola. It will become an indispensable part of your arsenal used to conquer HealthKit.</p><p>To learn more about Granola and other tools to help you use mobile health data, visit<a href="http://www.openmhealth.org/">www.openmhealth.org</a>. <em>Open mHealth is a non-profit startup making it easier to use and access mobile health data through an open standard, an open platform and community.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2cad50c78cb6" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/on-healthkit-granola-and-json-with-sherbit-2cad50c78cb6">On HealthKit, Granola, and JSON with Sherbit</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Facebook Partners With Shadowy ‘Data Brokers’ To Farm Your Information]]></title>
            <link>https://medium.com/sherbit-news/facebook-partners-with-shadowy-data-brokers-to-farm-your-information-1129a5878b05?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/1129a5878b05</guid>
            <category><![CDATA[big-data]]></category>
            <category><![CDATA[privacy]]></category>
            <category><![CDATA[facebook]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Mon, 25 Apr 2016 17:53:13 GMT</pubDate>
            <atom:updated>2016-04-25T17:52:58.617Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*H_WCNE9hooqlabnj.jpg" /></figure><p><strong>“It’s not a bug, it’s a feature”</strong></p><p>Last month, researchers with the <a href="http://www.privacycommission.be/">Belgian Privacy Commission</a> conducted a <a href="http://www.law.kuleuven.be/icri/en/news/item/icri-cir-advises-belgian-privacy-commission-in-facebook-investigation">comprehensive analysis</a> of Facebook’s new Data Use Policy and Terms of Service and concluded that the company is in <a href="https://www.techdirt.com/articles/20150224/09384530123/facebooks-updated-privacy-policy-breaches-eu-law-belgian-study-claims-other-countries-investigating.shtml">violation of European law</a>: it has authorized itself to continuously collect users’ location information, sell users’ photos for advertising purposes, and track both users’ and non-users’ browsing habits across the internet — while failing to educate users on the true extent of this ‘tracking,’ and making it prohibitively difficult for them to ‘opt-out.’ The researchers detailed many troubling aspects of Facebook’s data collection practices, including evidence that one of Facebook’s cookies is stored in every browser that visits a site with a ‘<a href="https://developers.facebook.com/docs/plugins/">Social Plugin</a>‘ (the embedded ‘Like’ and ‘Share’ buttons), regardless of whether or not they are a Facebook user. Last week, Facebook’s VP of European Policy <a href="https://newsroom.fb.com/news/h/setting-the-record-straight-on-a-belgian-academic-report/">responded</a> with a blog laying out his criticisms of the report. In the post, he admitted that a ‘<a href="http://thehill.com/policy/technology/238399-facebook-claims-a-bug-made-it-track-people-not-on-facebook">bug</a>‘ may have been storing tracking cookies on non-users’ browsers, but insisted that “this was not our intention,” and “a fix… is already under way.” But ‘buggy’ cookies for ‘Social Plugins’ are just a small part of Facebook’s tracking of ‘non-users’ — Facebook is no longer just a social media website, it is a massive advertising business invested in tracking <em>everyone’s</em> consumer spending habits, <em>on</em> the internet and <em>off</em>.</p><p>In the past few years, Facebook has made some <a href="http://www.businessinsider.com/facebook-is-about-to-launch-a-huge-play-in-big-data-analytics-2013-5">major moves</a> in the web advertising business. In 2013, Facebook purchased <a href="http://atlassolutions.com/">Atlas</a>, a huge internet ad server (previously owned by Microsoft) responsible for hosting somewhere between <a href="http://www.leadledger.com/tech/category/AdServer_DCO">ten and fifteen percent</a> of all internet ads. Atlas is second only to Google’s <a href="http://en.wikipedia.org/wiki/DoubleClick">DoubleClick</a>, and the acquisition made Facebook the second biggest web advertiser in the world. After the deal, Mark Zuckerberg boasted: “We believe the Atlas platform will help us demonstrate even more clearly the connection between ad impressions and purchases. We could help marketers measure the effectiveness of their ad impressions better not just on Facebook, but across the entire internet.” The Atlas acquisition gives Facebook a huge slice of the web advertising pie. Facebook can use Atlas to correlate purchases with browsing behavior on <em>other</em> (non-Facebook) sites — then, advertisers who are already working with Facebook can pay a small premium to get a more <a href="http://techcrunch.com/2013/02/28/facebook-acquires-atlas/">holistic view</a> of their marketing campaigns’ effectiveness across the internet. The goal is to develop an effective “<a href="http://seekingalpha.com/article/1392101-facebooks-ceo-discusses-q1-2013-results-earnings-call-transcript">monetization engine</a>” for the social network: a smooth track between monitoring browsing behavior, delivering pertinent advertisements, and securing purchases.</p><p>In a <a href="http://www.businessinsider.com/facebook-is-about-to-launch-a-huge-play-in-big-data-analytics-2013-5%5C">meeting with Wall Street analysts</a> two years ago, Zuckerberg explained: “As people have looked more holistically at all the ad spending they are doing, what they find is that it’s not just the last click that matters but it’s all the impressions leading up to that click.” The ‘last click’ (before purchasing something online) gives very little information about <em>why</em> a customer made a purchase, because most people research and compare multiple products before deciding to buy something; knowing the ‘context’ for the decision helps marketers to establish <a href="http://www.clickz.com/clickz/column/2282207/embracing-the-reality-of-multitouch-attribution">accurate ‘attribution’</a> — Atlas’ goal is to achieve better ‘<a href="http://www.emarketer.com/Article/Bye-Bye-CookiesAtlas-Tracks-Consumers-Online-Offline-via-Facebook-IDs/1011661">multitouch attribution</a>,’ methods of analyzing how repeated exposures to ads influence purchasing decisions over time (using <a href="http://atlassolutions.com/2014/03/24/atlas-insight-series-how-often-do-multiple-cookies-represent-one-person/">multiple cookies</a> or other <a href="http://adage.com/article/digitalnext/cookies-cut-anymore-online-ad-measurement/292225/">unique identifiers</a> to <a href="https://www.eff.org/deeplinks/2013/04/disconcerting-details-how-facebook-teams-data-brokers-show-you-targeted-ads">track your browsing history</a>). Zuckerberg continued: “Importantly, we also drive sales offline. And offline people aren’t clicking through the purchase at all but they are actually walking into a store. So in some sense there is no last click… Our focus with Atlas is to take that technology and enable us to improve our ability to connect ad impressions to purchase behavior both offline and online, and not just on clicks but across different ad purchases people do.” The Facebook of the future will have a bit less to do with sharing content with your friends and increasingly more to do with targeted advertising <em>everywhere</em>.</p><p><strong>The data brokers</strong></p><p>News coverage about mass surveillance today generally focuses on the issue of bulk data <em>collection</em> — but Facebook’s ventures in the advertising business reveal an equally pressing issue: data <em>correlation</em>, combining massive, disparate datasets to create detailed profiles of individuals’ behaviors. Around the same time as the Atlas acquisition, Facebook began partnerships with four major ‘data broker’ firms: <a href="http://www.datalogix.com/">Datalogix</a>, <a href="http://www.epsilon.com/">Epsilon</a>, <a href="http://www.bluekai.com/">BlueKai</a>, and <a href="http://www.acxiom.com/">Acxiom</a>. The ‘data brokers’ have a history that long precedes the internet, and it is important to make sense of their backstory to understand where we’re headed. In his book <a href="http://www.amazon.com/Data-Goliath-Battles-Collect-Control/dp/0393244814">Data and Goliath</a>, information security expert Bruce Schneier broke down the pre-internet ‘consumer surveillance’ streams into four categories:</p><p>1. Consumer records. Manufacturers keep records of what their customers order (clothing stores remember their customers’ sizes and preferred styles, airlines and hotels keep track of their frequent customers, etc.) and today this information is stored in electronic databases. ‘Retail loyalty’ cards streamline the process: they offer discounts to ‘loyal’ customers, to create detailed consumer profiles.</p><p>2. Direct marketing. Companies that send paper mail want to make sure they’re not wasting postage on people who aren’t interested in their products, so advertising firms assemble lists of people who are more likely to want the mail. This is accomplished by doing demographic research and by checking customer lists from other, related businesses (magazine subscriptions, for example).</p><p>3. Credit bureaus. These companies collect detailed credit information and sell it to banks trying to determine whether to give out loans, and at what rates. This is a very resource-intensive method of surveillance, so it’s only used when a lot of money is at stake — issuing credit cards, or approving an apartment lease, and so on.</p><p>4. Government records. Birth and death certificates, driver’s license records, voter registration cards, marriage certificates, divorce papers, property records, arrest reports, and other official documents are all part of public record. Companies are increasingly able to download this information for free, or purchase it from the government for a small fee.</p><p>In the past two decades, credit bureaus and direct marketing companies began to combine these four streams to become ‘data brokers.’ These firms purchase your personal data from the companies you’ve done business with, combine it with all the other information they can find about you, and sell it to companies that want to know more about you. The amount of detail contained in these consumer ‘dossiers’ is astonishing — in Schneier’s words: “They collect demographic information: names, addresses, telephone numbers, e-mail addresses, gender, age, marital status, presence and ages of children in household, education level, profession, income level, political affiliation, cars driven, and information about homes and other property. They collect lists of things you’ve purchased, when you’ve purchased them, and how you paid for them. They keep track of deaths, divorces, and diseases in your family. They collect everything about what you do on the Internet.” And they collect it on <a href="http://arstechnica.com/business/2013/12/data-brokers-wont-even-tell-the-government-how-it-uses-sells-your-data/">nearly everyone</a> they can: Epsilon has a database of almost every American household, Acxiom adds another 700 million individuals worldwide, and Datalogix tops it off with records of “<a href="http://www.datalogix.com/audiences/online/">more than $1 trillion</a>” in offline purchases.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/640/0*F5ds1jz3XaFCsbAo.png" /></figure><p><em>Sample of list segments for sale by </em><a href="http://www.experian.com/"><em>Experian</em></a><em>.</em></p><p>It’s a big business: <a href="http://rt.com/usa/162076-data-broker-ftc-report/">billions of data points</a> equals <a href="http://www.mckinsey.com/insights/business_technology/big_data_the_next_frontier_for_innovation">billions of dollars</a>. <a href="http://paramountdirectmarketing.com/">Paramount Lists</a> sells the names of people with alcohol and gambling addictions, and targets individuals <a href="http://money.cnn.com/2014/06/01/pf/data-consumer-health/">based on drugs they’ve reported taking</a>, like Zoloft or Prozac. <a href="http://www.responsesolutionsllc.com/">Response Solutions</a> sells lists of people suffering from bipolar disorder, perhaps based on the appearance of <a href="https://books.google.com/books?id=7x3XBgAAQBAJ&amp;pg=PA132&amp;lpg=PA132&amp;dq=data+brokers+depression&amp;source=bl&amp;ots=xlpj2pIo5B&amp;sig=eEnpLHsqU94WvZQtr3lcUxfKJSY&amp;hl=en&amp;sa=X&amp;ei=f2QsVd-6KIOvogSvsIGwCQ&amp;ved=0CHgQ6AEwDQ#v=onepage&amp;q&amp;f=false">‘depression-related’ words</a> in their search histories (this kind of data is very <a href="http://www.bloomberg.com/news/articles/2014-12-10/they-know-you-buy-viagra-and-they-want-to-sell-you-more">valuable to pharmaceutical companies</a>). <a href="http://www.statlistics.com/">Statlistics</a> has lists of ‘gay and lesbian adults,’ possibly by making inferences from bars or clubs where they’ve used a credit card. <a href="http://www.infousa.com/">InfoUSA</a> can tell you who is a ‘suffering senior,’ or a ‘gullible’ one, and its clients have been implicated in various <a href="http://www.nytimes.com/2007/05/20/business/20tele.html">telemarketing scams</a> targeting the elderly. <a href="https://www.teletrackonline.com/">Teletrack</a> was <a href="http://www.ftc.gov/opa/2011/06/teletrack.shtm">fined by the Federal Trade Commission</a> for selling profiles of people who applied for <a href="http://en.wikipedia.org/wiki/Payday_loan">payday loans</a> to companies offering risky financial deals (selling financial information is illegal; everything else is fair game). <a href="http://www.equifax.com/home/en_us">Equifax</a> was also fined for selling lists of people who were <a href="https://www.ftc.gov/news-events/press-releases/2012/10/ftc-settlements-require-equifax-forfeit-money-made-allegedly">late on their mortgage payments</a> to a discount lender; the same company sells <a href="https://law.ku.edu/sites/law.ku.edu/files/docs/media_law/2014/Data_Broker_Industry_Senate_Report.PDF">detailed dossiers</a> documenting “whether a consumer purchased a particular soft drink or shampoo product in the last six months, uses laxatives or yeast infection products, OB/GYN doctor visits within the last 12 months, miles traveled in the last 4 weeks, and the number of whiskey drinks consumed in the past 30 days.”</p><p>The data brokers’ profiles are extremely thorough and provide penetrating insights into individuals’ lives. In an interview with <a href="http://www.cbsnews.com/news/data-brokers-selling-personal-information-60-minutes/">60 Minutes</a>, Federal Trade Commissioner Julie Brill said: “The dossiers are about individuals. That’s the whole point of these dossiers. It is information that is individually identified to an individual… I think most people have no idea that it’s being collected and sold… and that the information is basically a profile of them.” With the resources it receives from Acxiom and other ‘data brokers,’ Facebook could hypothetically serve soda ads to teenagers who recently purchased a soft drink at a convenience store, or diaper ads to parents who bought baby food at a department store. A ‘note’ on the ‘Facebook and Privacy’ page <a href="https://www.facebook.com/notes/facebook-and-privacy/ad-targeting-and-your-privacy-keeping-you-informed-on-ad-targeting-updates/517330291650191">attempts to comfort users</a> by insisting that “the process is designed so that no personal information is exchanged between Facebook and marketers (or the third parties those marketers work with).” But the truth of the situation is that the ‘data brokers’ <em>already own</em> your personal information — and their collaboration with the social network may allow them to assemble even more detailed profiles of your health and habits in the future. As a writer at Business Insider <a href="https://www.sherbit.io/facebook-partners-with-shadowy-data-brokers-to-farm-your-information/www.businessinsider.com/facebook-is-about-to-launch-a-huge-play-in-big-data-analytics-2013-5">commented on Zuckerberg’s </a>‘strategic vision’: “Most ordinary Facebook users don’t realize how ambitious these plans are. If you bought something with a credit or debit card in the last couple of years, you’re probably in Facebook’s data pool right now.”</p><p><strong>Acxiom: a case study</strong></p><p>One of Facebook’s largest ‘data broker’ partners, Acxiom, brags that it has (on average) <a href="http://www.nytimes.com/2012/06/17/technology/acxiom-the-quiet-giant-of-consumer-database-marketing.html">fifteen hundred</a> unique data points on more than half a billion individuals worldwide. To serve advertisements, Facebook creates “<a href="https://developers.facebook.com/docs/marketing-api/partnercategories/v2.3">Partner Categories</a>,” ‘targeting clusters’ that combine information collected by the social network (your posts, photos, geo-location data, etc.) with the data brokers’ record of “off-Facebook activity.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/683/0*na_DuH2Km9gbjseZ.png" /></figure><p><em>Facebook’s ad targeting interface</em></p><p><a href="https://www.eff.org/deeplinks/2013/04/disconcerting-details-how-facebook-teams-data-brokers-show-you-targeted-ads">Here’s how it works</a>. First, a company approaches Acxiom and asks for a particular market ‘segment’ (e.g., a list of parents who are likely to buy a family car soon), and Acxiom trawls its database for the e-mail addresses of every individual who falls into that category. Acxiom feeds these e-mail addresses through a <a href="https://crackstation.net/hashing-security.htm#normalhashing">hash algorithm</a>, obscuring and anonymizing the information, and these hashed e-mail addresses are sent to Facebook. Facebook then uses the same algorithm to hash the e-mail address of every Facebook user — wherever a hash Facebook creates matches up with the hash Acxiom created, Facebook places that user into the target ‘segment.’ Finally, Facebook displays the advertisement to all the targeted users, and returns a report describing the ad’s performance (how many people clicked it, their location, age, gender, etc.). <a href="http://www.bluekai.com/">BlueKai</a> has a similar process for reaching target ‘segments,’ using tracking cookies and an <a href="https://en.wikipedia.org/wiki/Web_bug">HTML pixel web bug</a> to create profiles based on users’ browsing history.</p><p>Although the data brokers have a lot of information about us, it is very difficult to get information about <em>them</em> — Acxiom routinely <a href="https://www.sherbit.io/facebook-partners-with-shadowy-data-brokers-to-farm-your-information/www.cbsnews.com/news/data-brokers-selling-personal-information-60-minutes/">declines interview requests</a> and is generally<a href="http://arstechnica.com/business/2013/12/data-brokers-wont-even-tell-the-government-how-it-uses-sells-your-data/"> very vague</a> about its data collection methods, citing confidentiality agreements. However, the firm <em>does</em> have a page called “<a href="http://www.acxiom.com/about-acxiom/privacy/us-consumer-choices/">US Consumer Choices</a>,” which lays out some options for regulating how Acxiom handles personal information. Recently, Acxiom set up a website called <a href="https://aboutthedata.com/">AboutTheData.com</a>, with the stated purpose of letting people “know more about the digital marketing information that Acxiom has, or to edit or opt-out of this data.” In order to use the site, you must prove your identity by providing your name, address, birthday, and the last four digits of your Social Security Number. If you choose to use the site, be careful — the <a href="https://aboutthedata.com/portal/terms-of-use">privacy policy</a> indicates that any information you provide “may be shared by Acxiom Corporation family of businesses.” In order to use the service, you permit Acxiom to “change these Terms of Use at any time, and by continuing to use the Site after [they] post a change, you will be deemed to have accepted the new Terms of Use.” On top of this, you waive the right to sue Acxiom in the future: “In any legal proceeding relating to your use of this Site, you agree to waive any right you may have to participate in any class, group, or representative proceeding and to waive any right you may have to a trial by jury. In other words, you agree that you are not allowed to file a class action or any kind of class or joint arbitration.”</p><p>For now, the “risks” may not outweigh the benefits (you can opt-out without joining the site). AboutTheData.com only allows you to see a tiny fraction of the actual data that Acxiom has collected about you, under a few broad categories (‘Characteristic Data,’ ‘Home Data,’ ‘Household Vehicle Data,’ ‘Household Economic Data,’ ‘Household Purchase Data,’ and ‘Household Interests Data’). The site invites you to ‘correct’ any erroneous or missing information; and, in fact, the website may simply be a surreptitious mechanism of collecting <em>more</em> information about you — Murat Kantarcioglu, a computer science professor at University of Texas-Dallas, <a href="http://www.forbes.com/sites/adamtanner/2013/09/05/bizarro-world-of-hilarious-mistakes-revealed-in-long-secret-personal-data-files-just-opened/">commented</a>: “My feeling is that this is bait to get people to clean their data without even paying them.” Kantarcioglu discovered that most of the data on the site was wrong or incomplete. When I accessed the site I found the same thing — for example, the site shared only <em>one</em> data point about ‘Household Vehicle Data,’ despite Acxiom’s extensive <a href="http://www.businessinsider.com/florida-made-63-million-selling-driver-information-last-year-2011-7">data-sharing agreements with state DMVs</a>. Similarly, the data point for ‘Online Purchasing Activity’ was simply set to ‘True,’ providing no details whatsoever about what Acxiom has inferred from my online spending habits.</p><p>If you want to opt-out (there’s one link for <a href="http://www.acxiom.com/about-acxiom/privacy/online-advertising-products-optout/">digital ads</a> and another for <a href="https://isapps.acxiom.com/optout/optout.aspx">‘traditional’ ads</a>) you’ll encounter this message: “Before You Opt-Out, Consider This: Opting out… will not prevent you from receiving marketing materials. Instead of receiving ads that are relevant to your interests, you will see more generic ads with no information to tailor content. For example, instead of getting a great offer on a hotel package in your favorite vacation spot, you might see an ad for the latest, greatest weight loss solution.” All things considered, the appeal makes some sense — internet advertisements aren’t going away. By using most internet services, you are making a ‘deal’ with the internet corporations; as Bruce Schneier <a href="https://books.google.com/books?id=MwF-BAAAQBAJ">put it</a>: “If you let us have all your data, we will show you advertisements you want to see and we’ll throw in free web search, e-mail, and all sorts of other services. It’s convenience, basically.” Given the norms of contemporary life, opting out of these services altogether isn’t easy for most people — it’s becoming more difficult to have a job without an e-mail address, or to keep up with childhood friends without social media. Anyway, it’s unclear how much opting out can really protect your privacy; opting out of Acxiom doesn’t reverse the fact that your data has already been sold to other companies. Furthermore, the data brokers frequently buy or license data from one another — as a writer at Ars Technica <a href="http://arstechnica.com/business/2013/12/data-brokers-wont-even-tell-the-government-how-it-uses-sells-your-data/">observed</a>, “This would effectively allow them to serve as each other’s backups… If a consumer requests deletion from one, the broker can comply and then re-request what it has already shared to its fellow brokers.”</p><p>So, where do we go from here? If you want to stop Facebook’s data broker partners from collecting and sharing information about you, the Electronic Frontier Foundation has put together a <a href="https://www.eff.org/deeplinks/2013/02/howto-opt-out-databrokers-showing-your-targeted-advertisements-facebook">helpful guide to opting out</a> of each one. But, as we have seen, this is only a partial solution to the general problem of continuous consumer surveillance. This problem inspired the creation of Sherbit: our goal is to create a platform for you to manage your <em>own</em> information — what it is, who has access to it, and how it is used. If you have to give up your data, you should have the tools to draw inferences from that data yourself. Sherbit and our forthcoming PrivacyMe tool are designed to help you monitor corporations’ data collection practices, so you can be better educated about where your electronic information is going. PrivacyMe will contain detailed reviews of web services’ privacy policies — in the future, Sherbit will ‘push’ notifications whenever an app’s privacy policy has changed, along with an explanation of these changes and their consequences. The process of opting out of data collection is often needlessly difficult and complex; eventually, we want this tool to streamline and simplify the process, by guiding you through the process. <a href="https://www.sherbit.io/">Sign up for the Sherbit beta list</a> to get an early look at our progress.</p><p><em>Originally published at </em><a href="https://www.sherbit.io/facebook-partners-with-shadowy-data-brokers-to-farm-your-information/"><em>www.sherbit.io</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1129a5878b05" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/facebook-partners-with-shadowy-data-brokers-to-farm-your-information-1129a5878b05">Facebook Partners With Shadowy ‘Data Brokers’ To Farm Your Information</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[NBA: Training With ‘Wearable’ Technology (Part 1)]]></title>
            <link>https://medium.com/sherbit-news/nba-training-with-wearable-technology-part-1-816bf273ed63?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/816bf273ed63</guid>
            <category><![CDATA[nba]]></category>
            <category><![CDATA[big-data]]></category>
            <category><![CDATA[sports]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Thu, 21 Apr 2016 21:07:43 GMT</pubDate>
            <atom:updated>2016-04-21T21:07:21.952Z</atom:updated>
            <content:encoded><![CDATA[<p>You already know about ‘smart watches’ and wrist-bound activity trackers, like Fitbit and UP by Jawbone — but professional athletes today have more futuristic ‘wearables’ at their disposal, for collecting even more detailed data about their workouts. We’re taking a look at how the NBA’s biggest stars are using some of these new technologies on the horizon. (Click <a href="https://www.sherbit.io/nba-playoffs-wearables-part-two/">here</a> to read part two.)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/700/0*GCZgQk2sNN7wsvZL.png" /></figure><p><strong>Stephen Curry: Athos Gear</strong></p><p>A few years ago, it seemed like <a href="http://www.goldenstateofmind.com/2015/2/23/8089061/warriors-fans-live-in-constant-fear-that-stephen-curry-will-get-injured">any discussion</a> about Stephen Curry’s game required some mention of his <a href="https://www.youtube.com/watch?v=jn0sLhDkBzk">fragile ankles</a>. After his miraculous <a href="https://www.youtube.com/watch?v=PxAeWZ5u1EE">fourth-quarter comeback</a> from down 20 points against the New Orleans Pelicans last week, nobody was talking about his injury history. The Golden State Warriors’ <a href="http://newsroom.pamf.org/2011/03/golden-state-warriors-sports-medicine-provider/">medical staff</a> has been taking good care of the “<a href="https://www.youtube.com/watch?v=QTHPlYdLoBI">Human Torch</a>“. As part of their efforts to better monitor players’ health, the Warriors have begun beta-testing a suite of <a href="http://www.bizjournals.com/sanfrancisco/blog/2015/03/warriors-wearables-athos-fitness-apparel-sensors.html">high-tech ‘smart clothing’</a> manufactured by Redwood City-based Athos. Chamath Palihapitiya, Athos’ co-founder and part-owner of the Warriors, said he hoped the apparel would provide a “more precise way to train athletes, allowing them to be more efficient and see fatigue before injury occurs.” Of course, these ‘wearables’ aren’t the reason for Curry’s good health and magical <a href="https://www.youtube.com/watch?v=TrsLbtzWIAk">MVP season</a>…but they give us an idea of the future of fitness tracking technology.</p><p>Typical wrist-bound activity trackers only measure steps taken, speed, and pulse, using <a href="https://www.sherbit.io/what-does-your-iphone-know-about-you/">motion sensors</a> that are also found in your normal smartphone hardware. Athos Gear combines motion sensors and breathing sensors with <a href="https://en.wikipedia.org/wiki/Electromyography">electromyography (EMG)</a>, to collect information about electrical activity in the skeletal muscles. Motor neurons transmit electrical signals that cause muscles to contract, and an electromyograph translates these signals into numerical values that can be charted and interpreted. Typically, EMGs are performed by inserting a needle directly into the muscle, or by taping electrodes to the surface of the skin; Athos is totally wireless. Because of its design, data from its breathing sensors isn’t as detailed as some <a href="http://spire.io/blog/2015/03/25/getting-started-with-spire-app/">other, more bulky sensors</a> — but it seems the trade-off was made so the material feels as close as possible to regular workout clothing.</p><p>Athos Gear comes in three pieces: a top, a pair of pants, and a plastic core. The top has sixteen sets of sensors: one for heart rate, another for breathing, and seven pairs for seven major muscle groups. The pants have twelve more sets of sensors for six major muscle groups. The core, which fits in a small pocket, <a href="https://en.wikipedia.org/wiki/Bluetooth">relays information</a> from the sensors to a smartphone app, where users can see which muscle groups are activated <a href="https://www.youtube.com/watch?v=USjAPKHFuSA">in real time</a>. You can buy the set, but it ain’t cheap: the core alone costs $200, and each piece of apparel is an additional $100. Obviously, Athos won’t transform you into a <a href="https://www.youtube.com/watch?v=BDgG4QQXhOk">Splash Brother</a> overnight — their partnership with the Warriors is an effective marketing tactic, but playing in the NBA requires a lot more than high-tech clothing. Still, if you’re looking for more insight into your squats and lifts (and you have cash to burn), give them a try; we’ll work on ways to make that data <a href="https://www.sherbit.io/sherbit-and-activity-trackers/">more useful</a>.</p><p><em>Athos Gear commercial</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/528/0*S6Ih2qGJH9Q4D-2p.png" /></figure><p><strong>Jason Kidd: Catapult OptimEye</strong></p><p>Today, Jason Kidd will be coaching a young Milwaukee Bucks team on the brink of elimination against a championship-hopeful Chicago Bulls. But it wasn’t long ago — only two years, in fact — that he was a forty-year-old veteran returning from injury to a disappointing New York Knicks squad. To help confirm that he was healthy and game-ready, Knicks trainers attached a matchbook-sized motion-sensing device to Kidd’s jersey and compared his performance to benchmark readings set in the preseason; he ‘passed,’ and was cleared to play. The ‘OptimEye,’ manufactured by the Australian firm Catapult Sports, is taking off in American professional leagues; Catapult has <a href="http://www.forbes.com/sites/alexkonrad/2013/05/08/aussie-tech-catapult-gps/">secured contracts</a> with five NBA teams and six NFL teams, providing a suite of wearable hardware and analytics software for $100,000 per year. The spread of biometric analysis in American pro sports has <a href="http://espn.go.com/nba/story/_/id/11629773/new-nba-biometric-testing-less-michael-lewis-more-george-orwell">invited comparisons to Orwell’s 1984</a> — but in reality, these tools are just a logical progression of existing methods of analyzing athletes’ performance.</p><p>The OptimEye system works by inserting a sensor unit in a player’s jersey, between the shoulder blades (near the <a href="http://www.innerbody.com/image_skel05/skel52_spine.html">T1 vertebra</a>). It contains the typical motion sensors found in your run-of-the-mill fitness trackers — accelerometers, magnetometers, and gyroscopes — but it also uses <a href="https://en.wikipedia.org/wiki/Global_Positioning_System">GPS</a> to track players’ movements in three-dimensional space (or special antennas, for indoor arenas and stadiums). Catapult sees their technology as complementary with the high-tech <a href="http://grantland.com/features/the-toronto-raptors-sportvu-cameras-nba-analytical-revolution/">SportVU cameras</a> that are installed in every NBA arena; these cameras were initially <a href="https://newsela.com/articles/basketball-data/id/4149/">developed by the Israeli military</a> as an optical missile-tracking system, and were adapted to precisely track players’ movements in athletic events. The cameras are extremely effective at analyzing in-game tactics, but they can only track visible movement — they have difficulty collecting information on the <em>acceleration</em> on a jab step, the <em>force</em> exerted in a charging foul, or changes in cardiovascular activity, for example.</p><p>Nearly two-dozen NBA teams use the OptimEye (and similar technology) during practices, and the <a href="http://grantland.com/the-triangle/the-data-flow-continues-nba-d-league-will-monitor-player-heart-rate-speed-distance-and-more/">NBA Development League</a> has begun incorporating the devices into all regular league play; for the time being, however, the sensors remain prohibited in real NBA games. Even in the NBA, there are concerns over the <a href="https://www.sherbit.io/the-insurance-industry-and-the-quantified-self/">ownership of data</a>. Right now, the teams own the hardware, and general managers make personnel decisions based on information it collects. But because insights into players’ long-term health and injury tendencies could significantly influence their future contracts, the <a href="https://en.wikipedia.org/wiki/National_Basketball_Players_Association">National Basketball Players’ Association</a> wants players’ agents to be able to see the data as well. This will become a hot issue when it comes time to negotiate the league’s <a href="https://www.sbnation.com/nba/2014/7/1/5861394/nba-free-agents-2017-lockout">next collective bargaining agreement</a> in 2017. By then, it will likely be much cheaper to mass-produce devices like the OptimEye, and they’ll eventually <a href="http://ideas.ted.com/what-will-sports-look-like-in-the-future-three-ted-experts-discuss/">trickle down</a> to the average ‘weekend warrior.’</p><p><em>Catapult OptimEye in action</em></p><p><em>Originally published at </em><a href="https://www.sherbit.io/nba-playoffs-wearables-part-one/"><em>www.sherbit.io</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=816bf273ed63" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/nba-training-with-wearable-technology-part-1-816bf273ed63">NBA: Training With ‘Wearable’ Technology (Part 1)</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[‘Wearables’ In Court: How Your Electronic Data Becomes Evidence]]></title>
            <link>https://medium.com/sherbit-news/wearables-in-court-how-your-electronic-data-becomes-evidence-e6a2a95eed0e?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/e6a2a95eed0e</guid>
            <category><![CDATA[privacy]]></category>
            <category><![CDATA[big-data]]></category>
            <category><![CDATA[wearables]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Tue, 19 Apr 2016 18:25:12 GMT</pubDate>
            <atom:updated>2016-04-11T22:13:02.264Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/620/0*Q9pzswPIipSMoCm6.jpg" /></figure><p><strong>Expert Testimony</strong></p><p>Over the past two decades, a large body of case law has developed concerning the admissibility of computer data–or, as it’s called in legal parlance, “<a href="https://en.wikipedia.org/wiki/Electronically_stored_information_(Federal_Rules_of_Civil_Procedure)">electronically stored information</a>“–as evidence. Records of e-mails and text messages have become a <a href="https://apps.americanbar.org/litigation/committees/trialevidence/articles/012511-electronic-evidence.html">driving force</a> behind many court decisions in the United States. But American courts have not yet had to deal with one form of data that is growing increasingly common: information collected by ‘wearable’ technology. A recent case in the Canadian courts has stimulated <a href="http://www.theatlantic.com/technology/archive/2014/11/when-fitbit-is-the-expert-witness/382936/">public discussion</a> around the topic–and raised more questions about electronic surveillance and common law jurisprudence.</p><p>A young woman in Calgary, Alberta was working as a personal trainer when she was injured in a car accident; she filed a personal injury lawsuit, and was tasked with proving that she should be awarded compensation. Typically, a physician is asked to perform a physical examination and testify in court–but Richard Hu, a Calgary-based surgeon who was often called as an expert witness in these cases, devised a novel legal tactic. Hu is the founder and CEO of <a href="http://vivametrica.com/">Vivametrica</a>, a firm that aggregates information collected from thousands of activity trackers to do population-level behavioral analysis. He approached the lawyers representing the personal trainer, and suggested that they ask their client to wear a Fitbit for several months, and compare the data to the benchmarks set by Vivametrica’s algorithms. If her recorded activity was below the ‘average’ for her demographic, her injury claim would be justified.</p><p>It was a brilliant marketing move that generated <a href="http://www.forbes.com/sites/parmyolson/2014/11/16/fitbit-data-court-room-personal-injury-claim/">a lot of press coverage</a> for Hu’s company–but it was also a cunning legal maneuver. Whereas in the past the defendant’s attorney may have hired a private investigator to follow the plaintiff and collect evidence contradicting her claim (or ‘follow’ their social media presence, as in one medical malpractice suit that was settled quickly after the patient uploaded a photo of themselves <a href="http://www.curryandfriend.com/news-updates/health-care-and-medical-malpractice-news/195-wearable-technology-and-biological-data-mining">at a bull-riding event</a>), the plaintiff was now placing <em>herself</em> under continuous surveillance. “Prior to this, all we really had to put forth to the insurance companies was what our client was saying to her doctors,” one of the attorneys representing the personal trainer <a href="http://www.macleans.ca/society/technology/expert-witness-will-information-from-a-fitbit-hold-up-in-court/">told Maclean’s</a>. “If we have actual evidence to show that her activity levels are lower for somebody her age, then that backs up what she’s saying. It’s all about evidence, at the end of the day.”</p><p>Vivametrica and other “population health management” firms, like <a href="http://welltok.com/">Welltok</a> and <a href="http://staywell.com/">Staywell</a>, are part of a massive (and growing) health surveillance industry. It is now <a href="http://www.nytimes.com/interactive/2014/health/paying-till-it-hurts.html">common understanding</a> that public health care costs are <a href="http://economix.blogs.nytimes.com/2013/06/27/a-world-of-rising-health-care-costs/">rising rapidly</a> around the world–at the same time, the United States alone will face a <a href="http://www.washingtonpost.com/news/to-your-health/wp/2015/03/03/u-s-faces-90000-doctor-shortage-by-2025-medical-school-association-warns/">shortage of nearly 100,000 physicians</a> by 2025. But aside from the macro-level problems of public health, there is <a href="http://techcrunch.com/2012/01/10/doctors-or-algorithms/">a lot of money at stake</a>: venture capitalists poured <a href="http://techcrunch.com/2015/07/02/venture-investment-in-healthcare-declines-through-q2-after-record-2014/">seven billion dollars</a> into health technology last year, as the mantra “<a href="http://techcrunch.com/2012/01/10/doctors-or-algorithms/">we need algorithms, not doctors</a>” begins to take hold in Silicon Valley.</p><p><a href="https://www.youtube.com/watch?v=-8bQxbyXVSc">https://www.youtube.com/watch?v=-8bQxbyXVSc</a></p><p><em>Democracy Now: “Is Obamacare Enough?”</em></p><p>In a <a href="https://www.sherbit.io/the-insurance-industry-and-the-quantified-self/">previous post</a>, we discussed in some detail the complex relationship between insurance companies and health technology manufacturers–one of the major issues we investigated was the incorporation of fitness trackers into ‘corporate wellness’ programs, to monitor employees’ health and determine insurance rates. A significant question emerged: Who defines what positive (or ‘healthy’) behavior is? What’s at stake when “<a href="http://www.claimscanada.ca/issues/article.aspx?aid=1003150733&amp;er=NA">black box</a>” hardware and “<a href="http://www.nytimes.com/2015/05/28/business/dealbook/jawbone-sues-fitbit-over-data-plundering-by-ex-employees.html">trade secret</a>” algorithms become our functional ‘representatives’ in the eyes of courts and corporations? It’s an abstract problem, and we’re only beginning to scratch the surface here.</p><p>The Calgary lawsuit is an example of ‘wearable’-generated data being used to <em>support</em> a claimant in an injury case–but a related lawsuit in Nova Scotia hints at some hidden costs and dangers of our technological ‘progress.’ In December 2005, Peter Laushway, a Canadian businessman who sold health products on commission over the internet, suffered serious injuries in a motor vehicle accident. Laushway <a href="http://www.canadianappeals.com/2014/03/05/the-production-of-private-but-relevant-electronic-information-in-civil-litigation-the-nsca-weighs-in/">filed an insurance claim</a> for lost income: he argued that the accident prevented him from completing sedentary tasks — like sitting for long periods of time in front of his computer — that were necessary to do his job. The insurance company demanded that he prove his claim by turning over his computer hard drive to a forensic expert for analysis, and their request was approved by the chambers judge.</p><p>Laushway filed an appeal, arguing that the request was a breach of his privacy; the appeals court in Nova Scotia was tasked with determining how to balance Laushway’s ‘<a href="https://en.wikipedia.org/wiki/Expectation_of_privacy">reasonable expectation</a>‘ of privacy with his duty to provide the court with relevant information about his ability to work. Eight years later, the court finally <a href="http://www.canlii.org/en/ns/nsca/doc/2014/2014nsca7/2014nsca7.html">reached a decision</a>: “There was a clear, direct link between the hours he said he spent at his computer, and his income as a salesman. The information was relevant, and the respondents should be entitled to access that information.” So long as it was restricted to metadata relevant to the facts of the case — how much time Laushway spent on his computer, rather than the actual contents of his hard drive — the insurance company was allowed to see Laushway’s data.</p><p>The parallels between the Calgary and Nova Scotia cases are clear — they both involve attempts to prove to an insurance company that one’s health and ability to earn income have been diminished. But whereas the woman in Calgary volunteered to wear an activity tracker with the specific intention of collecting evidence to support her claim, Laushway’s data was taken from him without his consent, under the effective coercion of a court order. Laushway’s case raises the possibility of a court — or any government agency — filing a <a href="https://en.wikipedia.org/wiki/Subpoena">subpoena</a> compelling a ‘wearable’ manufacturer to release a user’s data, without that user’s knowledge or permission. Furthermore, it illustrates the scope of the problem of passively-collected data: ‘wearables’ are just one pole of the “Internet of Things.” What happens when all your stuff is connected to the internet–and your car (or your shirt, or shoes, or television, let alone your phone) is snitching on you?</p><p><strong>Quantified Self-Incrimination</strong></p><p>Although we’ve only discussed civil litigation so far, the scope of the problem far exceeds insurance claims and personal injury lawsuits. The ‘wearables’ cases illustrate the fuzzy boundaries between corporate surveillance (data collection from consumer electronics) and the more general regime of government surveillance. The privacy policies of ‘wearable’ devices all anticipate the possibility that their information will be requested by courts; for example, Fitbit’s <a href="http://www.fitbit.com/terms">terms of service</a> state that the company will surrender a user’s data if “disclosure is reasonably necessary to comply with law, regulation, valid legal process (e.g. subpoenas or warrants served on us), or governmental or regulatory request.” These kinds of phrases are commonplace in nearly every terms of service you have agreed to–and its often up to the internet companies’ attorneys to decide what constitutes ‘reasonably necessary’ compliance.</p><p>In the United States, the right to privacy of electronic data is limited by the so-called “<a href="http://www.theatlantic.com/technology/archive/2013/12/what-you-need-to-know-about-the-third-party-doctrine/282721/">third-party doctrine</a>.” In 1976, Michael Lee Smith robbed a woman in Baltimore, and began making threatening phone calls to her home. Later, the police spotted a man matching the robber’s profile driving near the scene of the crime; they took down his license plate number and learned Smith’s identity. Without a warrant, the police asked the phone company to install a ‘<a href="https://en.wikipedia.org/wiki/Pen_register">pen register</a>‘ to record the numbers Smith was dialing; once they discovered Smith was calling the victim, they got a warrant to search his home and arrested him for the robbery. In 1979, the Supreme Court ruled that the police did not need a warrant to install the pen register: “This Court consistently has held that a person has no legitimate expectation of privacy in information he voluntarily turns over to third parties.”</p><p>The <a href="https://en.wikipedia.org/wiki/Electronic_Communications_Privacy_Act">Electronic Communications Privacy Act</a> (ECPA) regulates how companies must respond to government requests for electronic data. The ECPA was passed in 1986 and, like much of the statutory law around electronic privacy, it is poorly equipped to handle the realities of today’s internet. A clear case of the ECPA’s shortcomings is the process for filing a subpoena. In most jurisdictions, there is no requirement for a judge to review a subpoena before it is issued — even the <a href="http://www.acslaw.org/acsblog/ecpa-reform-real-privacy-protection-within-reach">SEC or the IRS</a> can make these requests, and they often do. Under the ECPA, any “communications” held by a third-party for more than 180 days are <a href="http://www.digitaltrends.com/opinion/google-transparency-report-ecpa-reform/">considered “abandoned”</a> by the original owner. The Justice Department <a href="http://lawprofessors.typepad.com/conlaw/2010/09/updating-the-ecpa-electronic-communications-privacy-act.html">has argued</a> that an email or text message, once opened by its recipient, can be obtained with a subpoena alone–these arguments <a href="http://www.ca6.uscourts.gov/opinions.pdf/10a0377p-06.pdf">have been rejected</a> by some federal courts, but the issue remains unresolved in other parts of the country.</p><p>To a certain extent, it’s up to each company’s discretion how to respond to requests under the ECPA; for example, Google’s policy is to require a search warrant for any requests pertaining to the actual <em>content</em> of a user’s data. For subpoenas targeted at Gmail accounts, Google will restrict the surrendered data to subscriber information (e.g., name, associated email addresses, phone number, etc.) and a list of IP addresses indicating where a user has logged in (with their associated timestamps). With a court order (which requires proof that the requested information is relevant to a criminal investigation), Google will provide more detailed metadata–like a list of a user’s emails, with all content stripped except their IP addresses, timestamps, and “to” and “from” fields. Only once served with a warrant (where a judge has established <a href="https://en.wikipedia.org/wiki/Probable_cause">probable cause</a>) will Google turn over a user’s search history, Gmail messages, documents, photos, and so on.</p><p><a href="https://www.youtube.com/watch?v=MeKKHxcJfh0">https://www.youtube.com/watch?v=MeKKHxcJfh0</a></p><p><em>How Google responds to U.S. search warrants</em></p><p>We only know about Google’s practices because their legal team produces a detailed “<a href="http://www.google.com/transparencyreport/">Transparency Report</a>” every year, something the vast majority of internet companies don’t (or can’t) do. And in spite of its considerable legal resources, Google doesn’t always succeed in defying the courts: last year, after Google refused to hand over a man’s emails to his (former) employer without the man’s explicit consent, a California judge ruled that courts can <a href="http://www.computerworld.com/article/2863378/court-reaffirms-think-before-you-email.html"><em>order</em> a litigant to consent</a>, allowing the court to obtain those emails using a subpoena alone. In <a href="http://mashable.com/2015/03/19/us-can-access-old-email/">another important case</a> (still ongoing) Microsoft is mounting its own challenge to the Justice Department’s attempts to obtain users’ emails without warrants. Unfortunately, in many cases, the mere threat of “contempt of court” sanctions is enough to secure compliance from internet companies–even if a subpoena has been filed <a href="https://www.eff.org/deeplinks/2014/11/telecoms-accepted-90-plus-illegitimate-subpoenas-new-mexico">improperly or illegally</a>.</p><p>And we still haven’t even mentioned the <a href="https://en.wikipedia.org/wiki/Foreign_Intelligence_Surveillance_Act">Foreign Intelligence Surveillance Courts</a>. The Foreign Intelligence Surveillance Act was passed in 1978, in response to revelations that the executive branch had been <a href="https://en.wikipedia.org/wiki/COINTELPRO">spying on political and activist groups</a>. It created a court to oversee the surveillance activities of executive agencies; today, the court is effectively a ‘<a href="http://org/2013/06/13/191226106/fisa-court-appears-to-be-rubberstamp-for-government-requests">rubber stamp</a>‘ for those agencies. If you have been profiled as a suspect in a national security investigation — for example, by <a href="http://www.darkreading.com/risk-management/want-nsa-attention-use-encrypted-communications/d/d-id/1110475?">encrypting your emails</a>, searching for “<a href="http://www.slate.com/blogs/future_tense/2013/07/31/xkeyscore_nsa_targets_internet_users_who_search_for_suspicious_stuff.html">suspicious stuff</a>,” <a href="http://www.nytimes.com/2012/12/25/nyregion/occupy-movement-was-investigated-by-fbi-counterterrorism-agents-records-show.html">attending a protest</a>, or <a href="http://www.mintpressnews.com/us-judges-review-broad-surveillance-muslims-nypd/201282/">practicing Islam</a> — your electronic information might be obtained from an internet company, cloned, and stored in a <a href="http://www.wired.com/2012/03/ff_nsadatacenter/">government data center</a> somewhere, under the same legal precedents outlined above. And you may never learn who’s been looking at your information–because FISA requests <a href="http://www.nytimes.com/2013/07/07/us/in-secret-court-vastly-broadens-powers-of-nsa.html">are secret</a>, and compliance is secured through ‘<a href="https://www.aclu.org/national-security-letters">National Security Letters</a>‘ that prohibit the internet companies from talking.</p><p>There are mounting legal challenges to the U.S. government’s <a href="http://www.theguardian.com/world/2013/jun/06/us-tech-giants-nsa-data">dragnet surveillance programs</a>, with mixed results. In <a href="https://en.wikipedia.org/wiki/ACLU_v._Clapper">one case</a>, a federal judge ruled that <a href="http://www.theguardian.com/world/2013/jun/06/nsa-phone-records-verizon-court-order">collection of telephone metadata</a> en masse <a href="http://i2.cdn.turner.com/cnn/2013/images/12/27/sdny.nsa.pdf">was constitutional</a> according to the “third-party doctrine”; in <a href="https://www.eff.org/cases/klayman-v-obama">another case</a>, a different judge <a href="http://legaltimes.typepad.com/files/obamansa.pdf">reached the opposite conclusion</a>. <a href="https://www.schneier.com/blog/archives/2013/11/a_fraying_of_th.html">Thanks to Edward Snowden</a>, the attitudes of big internet companies toward government surveillance appear to be changing (if only because their cooperation with the government has been really bad PR). Google and <a href="http://digitaldueprocess.org/index.cfm?objectid=DF652CE0-2552-11DF-B455000C296BA163">other major internet companies</a> have put their resources behind the <a href="http://digitaldueprocess.org/index.cfm">Digital Due Process Coalition</a>, which seeks updates to the ECPA — including a clear search warrant requirement for all private communications, documents, and location data, and some protections against certain ‘bulk’ information requests. Thankfully, there have also been some <a href="http://www.truthdig.com/report/item/its_not_just_the_nsa_the_irs_is_reading_your_emails_too_20150710">renewed Congressional efforts</a> to revise large portions of the bill.</p><p><strong>Fight for the Future</strong></p><p>We are not far from a future in which a constant stream of your biometric information is being recorded and uploaded to the internet: Apple wants its watch to <a href="http://www.cnet.com/news/apple-watch-app-will-track-your-glucose-levels/">monitor diabetics’ blood sugar levels</a> throughout the day, Google plans to release medical-grade consumer devices that track things like <a href="http://techcrunch.com/2015/06/23/googles-new-health-wearable-delivers-constant-patient-monitoring/">skin temperature and light exposure</a>, future “smart homes” may passively <a href="https://www.sherbit.io/smart-homes-monitor-breathing-and-heart-rate/">analyze your breathing and heart rate</a> — all this, on top of <a href="https://www.sherbit.io/what-does-your-iphone-know-about-you/">the enormous amount of information</a> your phone’s sensors have already gathered about you. And although all this information is intimately related to your ‘health,’ data collected by consumer electronics are <a href="https://www.eff.org/issues/law-and-medical-privacy">not considered ‘healthcare information’</a> under the <a href="https://www.eff.org/glossary/hipaa">Health Insurance Portability and Accountability Act</a>, and therefore don’t receive the same protections as your medical records. It’s not difficult to imagine why an insurance agent, loan officer, or potential employer might be interested in this type of data.</p><p>The law is changing quickly — and so are the practices of the internet companies that depend on it. When we started Sherbit, we wanted to build an interface that broke down each application’s privacy policy, so you wouldn’t have to read through pages and pages of arcane legal jargon to understand how your data is being used, and how it is handled by legal institutions. Our plan was to ‘push’ updates to your phone whenever a privacy policy was changed, with an explanation of these changes in simple English. Our plan was far more ambitious than we’d realized–we’ve had to suspend that project for now, so we can focus all our efforts on completing <a href="https://www.sherbit.io/what-is-sherbit/">our iPhone application</a>. But the tools we’re building are just attempts to blunt the effects of the massive surveillance apparatus that is springing up around us. We need an active and engaged public, and comprehensive legislative solutions, or things will quickly get out of hand. There are a few promising signs, but the future is foggy. Stay tuned.</p><p><em>“I’ll put the cell phone privacy stuff in later” by </em><a href="http://www.sacbee.com/opinion/editorial-cartoons/jack-ohman/"><em>Jack Ohman</em></a><em>.</em></p><h3>Learn more about our app at <a href="http://www.sherbit.io/">www.sherbit.io</a></h3><p><em>Originally published at </em><a href="https://www.sherbit.io/wearables-in-court/"><em>www.sherbit.io</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e6a2a95eed0e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/wearables-in-court-how-your-electronic-data-becomes-evidence-e6a2a95eed0e">‘Wearables’ In Court: How Your Electronic Data Becomes Evidence</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[iDNA: Why Apple (and Google) Want Your Genetic Information]]></title>
            <link>https://medium.com/sherbit-news/idna-why-apple-and-google-want-your-genetic-information-9f0f0157b216?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/9f0f0157b216</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[tech]]></category>
            <category><![CDATA[apple]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Tue, 19 Apr 2016 18:25:04 GMT</pubDate>
            <atom:updated>2016-03-27T18:12:23.975Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*b-N3LmDpXNdnJ9tN.png" /></figure><p>Apple is turning smartphones into powerful tools for <a href="http://library.queensu.ca/ojs/index.php/surveillance-and-society/article/viewFile/3252/3215">medical surveillance</a>. Using the <a href="https://developer.apple.com/healthkit/">HealthKit</a> platform, patients can send readings from home medical monitors to their health-care provider, and receive <a href="http://www.technologyreview.com/news/536846/apple-and-ibms-plan-to-make-smarter-health-tracking-iphone-apps/">personalized advice</a> from the <a href="https://www.youtube.com/watch?v=ZPXCF5e1_HI">Watson Health Cloud</a> in return. With <a href="https://recode.net/2015/05/20/researchkit-apples-medical-data-experiment-explained/">ResearchKit</a>, scientists are building software for conducting large medical studies, collecting data from <a href="https://www.sherbit.io/what-does-your-iphone-know-about-you/">smartphone sensors</a> and surveys ‘pushed’ to users’ phones. Now, after an <a href="http://www.technologyreview.com/news/537081/apple-has-plans-for-your-dna/">exclusive report</a> by the M.I.T. Technology Review, rumors are swirling that Apple’s next major health initiative will involve genetic information collected from iPhone-owning volunteers. So far, the <a href="http://www.nytimes.com/2009/06/23/technology/23apple.html">historically secretive</a> company has refused to comment on the speculation — but why would Apple be interested in your genome?</p><p><strong>Genomics 101</strong></p><p>In <a href="https://en.wikipedia.org/wiki/Aneuploidy">most</a> human beings, every <a href="https://en.wikipedia.org/wiki/Somatic_cell">somatic cell</a> has 23 pairs of <a href="https://en.wikipedia.org/wiki/Chromosome">chromosomes</a> (one set from each parent) packed tightly together in the <a href="http://hyperphysics.phy-astr.gsu.edu/hbase/biology/celnuc.html">cell nucleus</a>, and each chromosome contains one DNA molecule. DNA is a <a href="https://en.wikipedia.org/wiki/Nucleic_acid">nucleic acid</a>, a <a href="https://en.wikipedia.org/wiki/Polymer">polymer</a> made up of smaller, repeating molecular units called <a href="https://en.wikipedia.org/wiki/Nucleotide">nucleotides</a>. Each nucleotide is composed of a carbon sugar molecule (called <a href="https://biology.stackexchange.com/questions/24786/why-deoxyribose-for-dna-and-ribose-for-rna">deoxyribose</a>, which gives DNA its name), a <a href="http://www.chem.ucla.edu/harding/IGOC/P/phosphate_group.html">phosphate group</a>, and one of four <a href="http://hyperphysics.phy-astr.gsu.edu/hbase/organic/base.html">nitrogen-containing bases</a>: adenine (A), thymine (T), cytosine (C), or guanine (G). DNA has the structure of a ‘double helix’ — chains of sugars and phosphates form the main supports, coiling around each other, linked together by pairs of nitrogenous bases: A always bonds with T, and G always bonds with C. These links are called “base pairs,” and the order of these pairs (or “<a href="https://en.wikipedia.org/wiki/Nucleic_acid_sequence">base sequence</a>“) is the “<a href="https://en.wikipedia.org/wiki/Genetic_code">code</a>” that stores <a href="http://plato.stanford.edu/entries/information-biological/">biological information</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/1*M48O5oOI5fN_MGx7gDHp_A.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*1swFF015m5MwHBUB.gif" /></figure><p>The “human genome” is the complete set of base sequences contained in the 46 chromosomes. It is estimated that 99.5 percent of the DNA sequence for all humans <a href="http://www.genome.gov/10001551">is identical</a> — the half of one percent of the sequence that varies between us accounts for the astonishing scope of human diversity. Two percent of the genome is involved in encoding <a href="http://www.nature.com/scitable/topicpage/protein-misfolding-and-degenerative-diseases-14434929">proteins</a>, chains of <a href="http://www.biology.arizona.edu/biochemistry/problem_sets/aa/aa.html">amino acid</a> <a href="https://en.wikipedia.org/wiki/Residue_%28chemistry%29#Biochemistry">residues</a> that perform a vast array of <a href="http://ghr.nlm.nih.gov/handbook/howgeneswork/protein">essential cellular functions</a>. There are twenty kinds of amino acids, and they can be placed in different orders to produce more than 100,000 kinds of proteins; specific nucleotide sequences contain the ‘<a href="http://www.nature.com/scitable/topicpage/translation-dna-to-mrna-to-protein-393">instructions</a>‘ for amino acid sequences that build specific proteins. In the past, most studies of genetic variation in humans focused on “<a href="http://ghr.nlm.nih.gov/handbook/genomicresearch/snp">Single Nucleotide Polymorphisms</a>” in these ‘coding’ regions, where a single nucleotide — A, T, C, or G — differs in the sequence.</p><p>To understand how these variations are linked to disease susceptibility and the effectiveness of medical treatments, an international research consortium began the <a href="http://www.genome.gov/10001772">Human Genome Project</a> in 1991, a nearly $3 billion endeavor to map and sequence the 3 billion nucleotides of a ‘<a href="https://en.wikipedia.org/wiki/Reference_genome">reference</a>‘ genome. Researchers developed a method called ‘<a href="http://www.yourgenome.org/facts/what-is-shotgun-sequencing">shotgun sequencing</a>,’ where the genome is <a href="http://learn.genetics.utah.edu/content/labs/pcr/">copied</a> and shredded into random pieces (like the blast pattern of a shotgun). The fixed-length fragments are inserted into an <a href="http://www.nature.com/scitable/definition/plasmid-plasmids-28">artificial chromosome</a> that can be grown in <a href="https://en.wikipedia.org/wiki/Escherichia_coli"><em>E. coli</em></a> bacteria — when the bacteria <a href="https://www.youtube.com/watch?v=27TxKoFU2Nw">replicates</a>, a ‘library’ of DNA clones is created. These clones are then broken up into even smaller fragments, to be sequenced using the <a href="https://en.wikipedia.org/wiki/Sanger_sequencing">‘traditional’ method</a> of tagging nucleotides with fluorescent dyes. Finally, a computer reconstructs the complete genome by tracing where each of the millions of fragments overlaps with another, and painstakingly piecing them back together — like a massive, electronic jigsaw puzzle.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*6b-f6u_YVHqFRs2L.jpg" /></figure><p>It took scientists ten years to complete the <a href="https://www.genome.gov/10002192">first draft</a> map of the reference genome. Since then, sequencing methods <a href="https://en.wikipedia.org/wiki/DNA_sequencing#Next-generation_methods">have advanced</a> at an astonishing pace — last January, California-based <a href="https://www.illumina.com/">Illumina</a> unveiled a system that sequences more than five genomes per day, at a cost of <a href="http://www.nature.com/news/is-the-1-000-genome-for-real-1.14530">one thousand dollars per genome</a>. Empowered by the rapidly declining costs of technology, geneticists poured their research grants into sequencing and comparing the DNA of ‘sick’ and ‘healthy’ people, hoping to discover the culprit “diabetes genes” or “depression genes” responsible for illness. But they gradually began to realize that most diseases (with <a href="http://web.udl.es/usuaris/e4650869/docencia/GenClin/content/recursos_classe_%28pdf%29/revisionsPDF/mendeldiseases.pdf">some rare exceptions</a>) aren’t caused by a single genetic “error” — rather, a person’s risk is linked to combinations of hundreds, and perhaps tens of thousands, of variations in the base sequence.</p><p>In order to crack statistical problems of this scale, geneticists will require substantially larger databases — and more computing power — than previously imagined. As Arthur Toga, an Alzheimer’s disease researcher at <a href="https://adrc.usc.edu/">U.S.C.</a>, <a href="http://www.technologyreview.com/featuredstory/535016/internet-of-dna/">predicted</a>: “There’s going to be an enormous change in how science is done, and it’s only because the <a href="https://en.wikipedia.org/wiki/Signal-to-noise_ratio">signal-to-noise ratio</a> necessitates it. You can’t get your result with just 10,000 patients — you are going to need more. Scientists will share now because they have to.” How are researchers and physicians going to get access to exabytes of genomic information, on millions of patients from around the world? That’s where Apple, and the other internet giants, get involved.</p><p><strong>The “Internet of DNA”</strong></p><p>Imagine that you are diagnosed with cancer — your physician may order DNA tests on your tumor, knowing that every cancer is caused by specific genetic mutations in the cancerous cell. What if there were a global database of genomic information that your physician could query? She could look up every patient who shared your tumor’s specific mutations, what drugs those patients took, and how long they lived, providing some clues into the most effective treatment plan. Major internet companies are now competing for their slice of this potentially multi-billion dollar research industry: an “<a href="http://www.technologyreview.com/featuredstory/535016/internet-of-dna/">Internet of DNA</a>” for the “<a href="http://www.wired.com/insights/2014/11/the-internet-of-things-bigger/">Internet of Things</a>.”</p><p>In 2013, Google announced a new cloud computing service called “<a href="http://www.technologyreview.com/news/532266/google-wants-to-store-your-genome/">Google Genomics</a>.” In collaboration with genomic scientists, software engineers at Google have built an <a href="http://www.webopedia.com/TERM/A/API.html">interface</a> that allows researchers to easily migrate large amounts of genetic information onto Google’s servers; there, scientists can perform experiments with the same <a href="https://cloud.google.com/bigquery/">database analysis technology</a> used by Google’s <a href="https://en.wikipedia.org/wiki/Web_crawler">web crawlers</a> (to index millions of websites) and <a href="http://www.informationweek.com/software/information-management/google-launches-bigquery-analytics-service/d/d-id/1104153?">ad networks</a> (to track billions of consumers). Although “BigQuery” was initially marketed as a ‘<a href="https://gigaom.com/2012/05/01/google-opens-up-its-biq-query-data-analytics-service-to-all/">business analytics</a>‘ tool, Google engineers seized on the possibility of scientific applications, <a href="http://www.technologyreview.com/news/532266/google-wants-to-store-your-genome/">said</a> Google Genomics director David Glazer: “We saw biologists moving from studying one genome at a time to studying millions. The opportunity is how to apply breakthroughs in data technology to help with this transition.”</p><p><a href="https://youtu.be/ExNxi_X4qug">https://youtu.be/ExNxi_X4qug</a></p><p><em>“Big genomic data on Google Cloud Platform”</em></p><p>Running fourteen sequencing machines at once, the <a href="https://www.broadinstitute.org/">Broad Institute</a> of M.I.T. and Harvard can decode one genome <a href="https://www.broadinstitute.org/scientific-community/science/platforms/genomics/history">every 32 minutes</a>, generating 200 TB of raw data — in other words, it would take the institute <em>two months</em> to produce the equivalent of what gets uploaded to YouTube in <em>one day</em>. With Google’s resources, scientists at Broad have developed a <a href="http://techcrunch.com/2015/06/24/google-partners-with-broad-institute-of-mit-and-harvard-to-bring-genome-analysis-tool-to-its-cloud-platform/">Genome Analysis Toolkit</a>, freely available to other genomics scientists, for use on Google’s Cloud Platform: from a <a href="https://en.wikipedia.org/wiki/Command-line_interface">command line</a>, a researcher can now easily identify the common variations among a set of genomes, or do a ‘quality control’ check for poorly mapped sections of a genome dataset. When Atul Butte, a bioinformatics expert at <a href="http://synapse.ucsf.edu/articles/2015/02/18/interview-new-institute-computational-health-sciences-director-atul-butte">U.C.S.F.</a>, heard Google announce its platform last year, <a href="http://www.technologyreview.com/news/532266/google-wants-to-store-your-genome/">he said</a> he now understood “how travel agents felt when they saw Expedia.”</p><p>Amazon has pursued a similar strategy with <a href="https://aws.amazon.com/glacier/">Amazon Web Services</a> and their database analysis toolset “<a href="https://aws.amazon.com/health/genomics/">Redshift</a>.” Now, Google and Amazon are engaged in a ‘<a href="http://www.reuters.com/article/2015/06/05/us-health-genomics-cloud-insight-idUSKBN0OL0BG20150605">price war</a>‘ to store genetic information in bulk, as the two begin competing for major clients: Google has partnered with the <a href="https://en.wikipedia.org/wiki/Autism_Speaks">Autism Speaks</a> foundation (to study the genomes of affected children and their parents) and <a href="https://tutegenomics.com/">Tute Genomics</a> (which owns a database of 8.5 billion human DNA variants, annotated with their relative frequency, associated traits, and correlate drug effectiveness), while Amazon has scored contracts with the <a href="https://en.wikipedia.org/wiki/Multiple_Myeloma_Research_Foundation">Multiple Myeloma Research Foundation</a>, <a href="https://www.niagads.org/adsp/content/home">Alzheimer’s Disease Sequencing Project</a>, and <a href="http://www.fiercebiotechit.com/story/amazon-targets-pharma-rd-others-new-cloud-storage/2012-08-22">various pharmaceutical companies</a>. Neither company will disclose how much genomics data it holds, but a <a href="http://www.reuters.com/article/2015/06/05/us-health-genomics-cloud-insight-idUSKBN0OL0BG20150605">recent Reuters report</a> speculated that Amazon’s “genome cloud” may be bigger.</p><p>For now, the major clients are mostly academic researchers and pharmaceutical companies — but many in the industry believe the focus will soon shift to clinics. Earlier this year, President Obama proposed a $215 million “<a href="http://www.technologyreview.com/news/534591/us-to-develop-dna-study-of-one-million-people/">precision medicine</a>” initiative, to advance the use of genomic information by health-care providers as described in the cancer diagnosis scenario above. A major component of the initiative is a national study of one million volunteers’ genomic profiles: participants in this ‘superstudy’ will have their electronic medical records turned over to researchers, and they’ll be equipped with additional sensors and activity trackers to monitor their behavior and environment in greater detail. The study will also combine data from more than two hundred ongoing genomic studies, by encouraging greater “interoperability” between disparate medical record systems and gene databases.</p><p>But there is a fundamental problem with ‘precision medicine’ without a clear solution: privacy. Because genome sequences are totally unique, researchers have found that it is <a href="http://www.nytimes.com/2013/06/18/science/poking-holes-in-the-privacy-of-dna.html">impossible</a> to ‘anonymize’ genetic information. Of course, it’s possible to <a href="https://en.wikipedia.org/wiki/Encryption">encrypt</a> databases, strip datasets of ‘<a href="https://en.wikipedia.org/wiki/Personally_identifiable_information">personally-identifiable</a>‘ information, and design interfaces that display only the minimally necessary level of detail — but clear standards and procedures for securing DNA do not yet exist. “I’ve heard almost nothing from any of the proponents of the Precision Medicine Initiative as to what structures they’re going to construct and put in place to protect this information,” the president of the <a href="http://www.councilforresponsiblegenetics.org/">Council for Responsible Genetics</a> recently <a href="http://america.aljazeera.com/watch/shows/fault-lines/articles/2015/5/11/is-dna-the-next-frontier-in-privacy.html">told Al Jazeera</a>. “I’m sure they’ll make all kinds of promises that they are appreciative of the issue.”</p><p><a href="https://youtu.be/A0b1xjxuFRo">https://youtu.be/A0b1xjxuFRo</a></p><p><em>“Supreme Court OKs Unfettered DNA Collection “</em></p><p>In this pioneering field, there isn’t much experience to draw from — but the case of 23andMe, a <a href="http://news.bbc.co.uk/2/hi/business/6682451.stm">Google-funded</a> ‘personal genomics’ company, illustrates the stakes. For $99, 23andMe offered DNA testing kits (a tube for ‘<a href="https://en.wikipedia.org/wiki/Saliva_testing">spit samples</a>‘) to be analyzed at the company’s labs; the company would then sequence the genome and return a detailed assessment of customers’ risks for common diseases. In 2013, the Food &amp; Drug Administration <a href="http://www.bbc.com/news/technology-25100878">banned the test</a> out of concern that the analyses weren’t accurate. But 23andMe’s real business is <a href="http://www.technologyreview.com/view/534006/23andmes-new-formula-patient-consent/"><em>mining</em> DNA information</a>, not analyzing it — and 80 percent of its customers have agreed to ‘donate’ their DNA data for research purposes. This ‘donated’ data is highly lucrative: <a href="https://en.wikipedia.org/wiki/Genentech">Genentech</a> recently paid <a href="http://www.forbes.com/sites/matthewherper/2015/01/06/surprise-with-60-million-genentech-deal-23andme-has-a-business-plan/">$60 million</a> for access to the genomes of 3,000 Parkinson’s Disease patients, and has arranged to share its database with <a href="https://en.wikipedia.org/wiki/Pfizer">Pfizer</a> for <a href="http://www.wired.com/2015/01/23andme-partners-big-pharma-find-treatments-hidden-genes/">undisclosed millions</a>. (Since the F.D.A. ruling, they’ve continued to shipping testing kits in Canada while selling more ‘limited’ <a href="https://www.google.com/search?q=23andme+genealogy+test&amp;ie=utf-8&amp;oe=utf-8">ancestry tests</a> in the U.S.).</p><p>The company defended these agreements in a <a href="http://america.aljazeera.com/watch/shows/fault-lines/articles/2015/5/11/is-dna-the-next-frontier-in-privacy.html">statement to Al Jazeera</a>: “23andMe customers consent to research. Ultimately, 23andMe customers own their data. Customers can decide to stop participating in research at any time and remove all of their information from our database.” Leaving aside for now the ethics of selling genomic information to <a href="http://www.independent.co.uk/news/world/asia/without-consent-how-drugs-companies-exploit-indian-guinea-pigs-6261919.html">unscrupulous</a>, <a href="http://www.democracynow.org/2007/1/19/big_bucks_big_pharma_marketing_disease">for-profit</a> pharmaceutical firms, it’s clear that future public health programs will have to develop flexible protocols that give research participants a say in how their information is shared, and the ability to revoke permissions in the future if necessary. To that end, the proposed Obama initiative will offer patients more access to data generated about them than is typical of research studies; the hope is that maintaining lines of communication will enable scientists to follow-up with research subjects with ‘interesting’ genomic profiles — impossible in most large medical studies of the past.</p><p>And there lies perhaps the most compelling argument for Apple’s rumored venture into genomics: the success of the <a href="http://fortune.com/2015/03/13/apple-researchkit-apps-available/">five existing ResearchKit apps</a> — studying Parkison’s, breast cancer, diabetes, asthma, and heart disease — has demonstrated Apple’s ability to rapidly recruit volunteers who will willingly share their biometric information, and become active participants in research projects. To join one of the planned studies, you must agree to a gene test ‘spit kit’ (similar to those used by 23andMe) to be submitted to an Apple-approved gene-sequencing center (the first of which are said to be at <a href="http://genomics.ucsf.edu/">U.C.S.F</a> and <a href="http://icahn.mssm.edu/departments-and-institutes/genomics">Mount Sinai</a>). The planned studies would look at a “gene panel” of some one hundred medically important genes related to common diseases, rather than a person’s entire genome — these targeted tests, at a large scale, may cost only a few hundred dollars each.</p><p><a href="https://en.wikipedia.org/wiki/Stephen_Friend">Stephen Friend</a>, a former pharma industry researcher, joined Apple after years of promoting ‘<a href="https://en.wikipedia.org/wiki/Sage_Bionetworks">open-source</a>‘ health research projects and ‘<a href="http://fusion.net/story/104983/the-inside-story-of-how-apples-new-biomedical-research-platform-was-born/">patient-centric</a>‘ controls for regulating access to medical information; he claims he chose to work on ResearchKit because of Apple’s <a href="http://www.wired.com/2015/06/apples-latest-selling-point-little-knows/">relatively superior</a> track record on user privacy. Google and Facebook “make their power by selling data,” said Friend in a <a href="http://fusion.net/story/104983/the-inside-story-of-how-apples-new-biomedical-research-platform-was-born/">recent interview</a>, “They get people information about other people. Apple has said, ‘We will not look at this data.’ Could you imagine Google saying that?” For now, it seems the data will be stored in a cloud, to be maintained by researchers, while insights from the research are pushed to users’ iPhones — but the writer who broke the story <a href="http://www.technologyreview.com/news/537081/apple-has-plans-for-your-dna/">speculated that</a>, one day, “it’s possible consumers might swipe to share ‘my genes’ as easily as they do their location.”</p><p>The Technology Review report concludes with this important observation: “No law stops individuals from sharing information about themselves. Thus one reason to ’empower patients,’ as rhetoric has it, is that if people collect their own data, or are given control of it, it could quickly find wide use in consumer apps and technologies, as well as in science.” This echoes one of the principal motivations behind the Sherbit platform, the possibility of ’empowering’ individuals to regulate how their own data is used — in particular, in pursuit of the <a href="https://www.sherbit.io/twitter-posts-predict-rates-of-heart-disease/">meaningful scientific insights</a> to be gained by studying this information in detail. In the <a href="https://www.sherbit.io/right-to-be-forgotten/">absence of legislation</a> effectively regulating how internet companies handle your information, the only option is to build tools for doing good things with this data, rather than simply allowing it to be <a href="http://www.reddit.com/r/tech/comments/32spb8/facebook_partners_with_shadowy_data_brokers_to/">exploited by advertisers</a>. As the prospect of an “iDNA” platform has shown, we must tread lightly — and always <a href="http://dilbert.com/strip/2009-07-01">put the end-user first</a>.</p><p><em>Originally published at </em><a href="https://www.sherbit.io/apple-wants-your-dna/"><em>www.sherbit.io</em></a><em> on August 31, 2015.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9f0f0157b216" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/idna-why-apple-and-google-want-your-genetic-information-9f0f0157b216">iDNA: Why Apple (and Google) Want Your Genetic Information</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Future Wearables: Smart Contact Lenses Analyze Your Tears]]></title>
            <link>https://medium.com/sherbit-news/future-wearables-smart-contact-lenses-analyze-your-tears-4fabf254d9b0?source=rss----988c3400cf87---4</link>
            <guid isPermaLink="false">https://medium.com/p/4fabf254d9b0</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[wearables]]></category>
            <category><![CDATA[tech]]></category>
            <dc:creator><![CDATA[Alex Senemar]]></dc:creator>
            <pubDate>Tue, 19 Apr 2016 18:24:57 GMT</pubDate>
            <atom:updated>2016-03-23T22:56:28.814Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/620/0*FL0nQft78iy8knDB.png" /></figure><p>The Sherbit Blog is back after a short hiatus! We were hard at work finishing the beta version of our iPhone client, and we’ve finally been approved for the <a href="https://itunes.apple.com/us/app/sherbit/id918023785">App Store</a>! (You’ll need an invitation code to start using the app. If you haven’t signed up yet, just click “Get Early Access” above; if you’ve already signed up, don’t worry — we’ll start moving people off the waitlist soon!) This week, we’ll be continuing our series on the “Future of Wearables”…previously we looked at <a href="https://www.sherbit.io/the-future-of-wearables-smart-underwear/">“smart” underwear</a> and <a href="https://www.sherbit.io/the-future-of-wearables-ingestible-sensors/">“ingestible” sensors</a>, two fascinating forays in medical technology. Now, Google is developing “smart” contact lenses to analyze key biomarkers found in your tears — and patent filings and public statements suggest even more ambitious plans for the technology.</p><p>Earlier this year, Google’s leadership announced a <a href="http://www.technologyreview.com/review/541806/what-will-alphabet-be-when-it-grows-up/">major restructuring</a> of the multinational conglomerate, separating many components of the business and placing them under an <a href="https://en.wikipedia.org/wiki/Holding_company">umbrella corporation</a> with the friendly name “<a href="http://www.technologyreview.com/review/541806/what-will-alphabet-be-when-it-grows-up">Alphabet</a>.” The profitable parts of Google — YouTube, web search, Maps, and advertising — will remain a part of ‘core Google.’ Meanwhile, Google’s experimental, research-oriented divisions — like the secretive <a href="https://en.wikipedia.org/wiki/Google_X">Google X</a>, and the home automation team at <a href="https://en.wikipedia.org/wiki/Nest_Labs">Nest Labs</a> — will be spun off as independent companies, to make clearer to investors where and how Google Alphabet is earning (and <a href="http://www.businessinsider.com/google-non-core-alphabet-businesses-could-lose-up-4-billion-a-year-2015-9">losing</a>) money.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/780/0*SmSLIuv9viGpnP1e.png" /></figure><p><em>A map of Google’s new corporate structure.</em></p><p>Google co-founder Sergey Brin recently revealed a new Alphabet subsidiary called “<a href="http://www.theverge.com/2015/8/21/9187131/google-life-sciences-becomes-first-alphabet-company">Google Life Sciences</a>,” formerly a division of Google X, dedicated to healthcare biotechnology research. We’ve covered some of Google’s Alphabet’s ambitious healthcare-related projects in previous posts — from ‘<a href="https://www.sherbit.io/right-to-forget/">curing death</a>‘ with “anti-aging” technology to ‘precision medicine’ using a <a href="https://www.sherbit.io/apple-wants-your-dna/">global database of DNA</a>. To support the Life Sciences division, Google has been funding and acquiring various biotechnology companies, in diverse fields as <a href="http://www.fiercebiotech.com/story/google-ventures-bets-oral-biologics-startup-rani-therapeutics/2013-08-29">oral drug delivery</a>, <a href="http://www.fiercebiotech.com/story/google-ventures-backs-dnanexuss-15m-round-rd-cloud-platform/2014-01-03">bioinformatics</a>, <a href="http://venturebeat.com/2013/07/22/synapdx-gets-15-4m-to-develop-a-blood-test-for-autism/">autism</a> and <a href="http://techcrunch.com/2014/10/28/googlex-reveals-nano-pill-to-seek-out-cancerous-cells/">cancer detection</a>, and even tremor-correcting <a href="http://bits.blogs.nytimes.com/2014/09/10/google-buys-lift-labs-in-further-biotech-push/">“smart” spoons</a>” for patients with Parkinson’s Disease. But Google Life Science’s first, highly-publicized project is a venture into a different (and <a href="http://www.pharmafile.com/news/197861/type-1-diabetes-market-value-double-2023">very profitable</a>) sector of the healthcare industry: diabetes.</p><p>‘<a href="http://www.mayoclinic.org/diseases-conditions/diabetes/basics/definition/con-20033091">Diabetes</a>‘ refers to a group of metabolic diseases related to the regulation of <a href="https://en.wikipedia.org/wiki/Insulin">insulin</a>, a hormone that helps convert sugar (<a href="http://hyperphysics.phy-astr.gsu.edu/hbase/organic/sugar.html">glucose</a>) in the blood into energy. Without insulin, the body <a href="http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hyperglycemia.html">cannot use glucose for fuel</a>, so it begins burning fat for energy — releasing <a href="http://www.diabetes.org/living-with-diabetes/complications/ketoacidosis-dka.html">toxic levels of ketones</a> into the bloodstream. In diabetic patients, either the pancreas is not producing enough insulin (“<a href="https://en.wikipedia.org/wiki/Diabetes_mellitus_type_1">type 1</a>“), or cells are not responding properly to the insulin produced (“<a href="https://en.wikipedia.org/wiki/Diabetes_mellitus_type_2">type 2</a>“). It is estimated that nearly <a href="https://www.washingtonpost.com/national/health-science/diabetes-becoming-alarmingly-common-worldwide-new-study-finds/2011/06/24/AGMkaFlH_story.html">10 percent</a> of adults worldwide have diabetes, and each year the disease kills more people than <a href="https://www.diabetesdaily.com/blog/2013/03/why-do-canceraids-get-more-support-than-diabetes/">breast cancer and AIDS combined</a>. The underlying causes of diabetes are not well-understood, but it is clear that its incidence is <a href="http://www.smithsonianmag.com/science-nature/the-unintended-and-deadly-consequences-of-living-in-the-industrialized-world-5324305/">much higher</a> in ‘developed,’ highly-industrialized countries.</p><p>People with diabetes must check their blood sugar levels throughout the day, and inject insulin at <a href="http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/insulin-routines.html">appropriate times</a> to keep their blood sugar under control. <a href="http://www.mayoclinic.org/diseases-conditions/diabetes/in-depth/blood-sugar/art-20046628">Many things</a> can cause blood sugar levels to change, often unexpectedly, and ‘pricking’ yourself four or five times a day can become very inconvenient. Some non-needle glucose monitoring systems have been explored in the past: a “<a href="http://www.diabetesnet.com/diabetes-technology/meters-monitors/future-meters-monitors/orsense">thumb cuff</a>” that applies pressure to temporarily occlude blood flow (like taking a <a href="http://news.bbcimg.co.uk/media/images/67018000/jpg/_67018295_hbp145897365.jpg">blood pressure</a> measurement), then detects <a href="http://www.diabetesnet.com/diabetes-technology/meters-monitors/future-meters-monitors/orsense">light transmitted through the finger</a> to make an inference about the blood’s content; or a <a href="http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm083294.htm">wristwatch</a> that uses low-level electric currents to pull fluid from the skin. But Google is betting that passively monitoring glucose levels in <em>tears</em> will be even less invasive, and more comprehensive, than other technologies for managing diabetes.</p><p><em>“Google reveals smart contact lens” (The Telegraph)</em></p><p>The lens consists of a wireless chip and miniaturized <a href="https://en.wikipedia.org/wiki/Glucose_meter">glucose sensor</a>, sandwiched between two soft layers of lens material — so the electronics don’t come into contact with the surface of the eye. They’re arranged outside the <a href="https://en.wikipedia.org/wiki/Pupil">pupil</a> and <a href="https://en.wikipedia.org/wiki/Iris_(anatomy)">iris</a>, to prevent obstructing the user’s vision; a small pinhole in the lens allows tear fluid to seep into the sensor, and a tiny antenna is used to gather, read, and analyze the data collected. According to the patent <a href="http://pdfaiw.uspto.gov/.aiw?PageNum=0&amp;docid=20150061837">filed earlier this year</a>, the system will be powered by <a href="http://www.technologyreview.com/news/413744/wireless-power-harvesting-for-cell-phones/">drawing energy from radio frequency waves</a> transmitted by a ‘reader’ device, possibly integrated into eyeglasses, jewelry, or clothing — anything that is close enough to communicate effectively with the lenses.</p><p>The “smart” contact lens project began with a research paper published by electrical engineers at the University of Washington, proposing lenses with <a href="http://spectrum.ieee.org/biomedical/bionics/augmented-reality-in-a-contact-lens">built-in electronics for ‘augmented reality’</a>–perhaps to aid people with impaired hearing, or as an indicator in a videogame. They pursued the idea with limited funding from the <a href="http://www.nsf.gov/">National Science Foundation</a>, but were <a href="http://www.cbc.ca/news/technology/google-contact-lens-could-help-diabetics-track-glucose-1.2500274">lured to Google</a> by the enormous resources it offered, particularly its <a href="http://www.theinquirer.net/inquirer/news/2283945/google-buys-into-semiconductor-firm-himax-for-google-glass">cutting-edge microchips</a>. In July 2014, the Swiss pharmaceutical conglomerate <a href="https://en.wikipedia.org/wiki/Novartis">Novartis</a> announced it would join the Google project, <a href="https://www.novartis.com/news/media-releases/novartis-license-google-smart-lens-technology">contributing expertise</a> from its eye care division <a href="https://en.wikipedia.org/wiki/Alcon">Alcon</a> (the <a href="http://www.clspectrum.com/articleviewer.aspx?articleid=109320">second-largest</a> contact lens supplier in the world) — in exchange, Novartis will receive exclusive <a href="http://www.wipo.int/sme/en/ip_business/licensing/licensing.htm">licensing rights</a> to distribute the product in the future.</p><p>The technology’s financial promise lies in its multitude of applications. Tears could also be tested for levels of cholesterol, sodium, and potassium — or to detect lacryglobin, a biomarker for <a href="http://www.ncbi.nlm.nih.gov/pubmed/11446459">many types of cancer</a>, as a warning system for cancer patients in remission. Beyond passive sensors, the Google team also has plans to develop more assistive applications; one prototype uses <a href="https://en.wikipedia.org/wiki/Photodiode">photodiodes</a> to detect light hitting the eye and infer where the eye is looking, to “<a href="http://www.prnewswire.com/news-releases/google-novartis-and-epgl-in-race-to-develop-first-autofocus-contact-lens-300116881.html">autofocus</a>” by adjusting the lens’ shape. Another team of researchers at University of Michigan is experimenting with <a href="http://www.cnn.com/2013/04/29/tech/graphene-miracle-material/">graphene</a> to develop lenses that detect <a href="http://coolcosmos.ipac.caltech.edu/cosmic_classroom/ir_tutorial/what_is_ir.html">infrared wavelengths</a> — opening the possibility of <a href="http://www.ns.umich.edu/new/releases/22042-new-tech-could-lead-to-night-vision-contact-lenses">night vision contacts</a>. Google’s patent filing suggests that the lenses could eventually incorporate <em>cameras — </em>for example, to alert a blind wearer to an approaching car by taking an image and converting the information to sound.</p><p><em>“Google Glass”</em></p><p>There are still many obstacles for researchers to overcome before the “smart” contact lenses become viable medical products–the safety of the devices, the cost to manufacture them, and the accuracy of their measurements, to name just a few. Still, the engineers at Google are optimistic. Before Babak Parviz joined Google as one of the project’s leads, he predicted <a href="http://spectrum.ieee.org/biomedical/bionics/augmented-reality-in-a-contact-lens">in a 2009 article</a> a sort of “<a href="https://en.wikipedia.org/wiki/Google_Glass">Google Glass</a>” in a contact lens: a ‘<a href="https://en.wikipedia.org/wiki/Head-up_display">heads-up</a>‘ display using an array of <a href="https://en.wikipedia.org/wiki/Microlens">microlenses</a> that “pushes” a virtual image forward, to within the range of a human eye’s focus. In combination with a smartphone, a high-resolution lens could then translate speech into captions, or show visual cues from a navigation system–and any of the features of the now-infamous “Google Glass” teaser (above). “With basic image processing and Internet access,” Parviz wrote, “a contact-lens display could unlock whole new worlds of visual information, unfettered by the constraints of a physical display.”</p><p>The British writer Jesse Armstrong imagined a evolved form of a similar technology in the short film “<a href="http://grantland.com/hollywood-prospectus/black-mirror-episode-3-the-entire-history-of-you-total-redo/">The Entire History of You</a>,” from the sci-fi anthology series <a href="https://en.wikipedia.org/wiki/Black_Mirror_(TV_series)"><em>Black Mirror</em></a>. (You can view the film in its entirety for free on <a href="https://www.youtube.com/watch?v=Sw3GIR70HAY">YouTube</a>, or via <a href="http://www.netflix.com/watch/70264856">Netflix</a>). In this vision of the future, ‘smart lenses’ are no longer merely ‘wearables’ — they are implants inserted at birth, persistently recording all human activity and uploading it to a ‘cloud,’ becoming ubiquitous with human experience in extremely affluent societies. This is not so different from Google’s Alphabet’s vision. Ray Kurzweil, Director of Engineering at Google, <a href="http://money.cnn.com/2015/06/03/technology/ray-kurzweil-predictions/">recently predicted</a> that in just fifteen years, human <em>brains </em>will be able to connect directly to the cloud: “Our thinking,” he proclaimed, “will be a hybrid of biological and non-biological thinking.” In Armstrong’s story, the protagonist is tormented by his inability to escape the images recorded by his ‘non-biological’ brain; if Kurzweil’s prophecy comes true, will humans be celebrating the triumph of Google’s technological genius… or cursing the cruel dystopia that came at its price? Stay tuned.</p><p><em>Originally published at </em><a href="https://www.sherbit.io/the-future-of-wearables-smart-lenses/"><em>www.sherbit.io</em></a><em> on October 30, 2015.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4fabf254d9b0" width="1" height="1" alt=""><hr><p><a href="https://medium.com/sherbit-news/future-wearables-smart-contact-lenses-analyze-your-tears-4fabf254d9b0">Future Wearables: Smart Contact Lenses Analyze Your Tears</a> was originally published in <a href="https://medium.com/sherbit-news">Sherbit News</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>